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There is a clinical need to restore craniofacial tissues affected by disorders of traumatic 
and/or congenital etiology. Effective therapies within this specialized region must achieve 
anatomic regeneration while also restoring function. The work in this dissertation attempts to 
identify mechanisms underlying the former while simultaneously elucidating the latter using 
mastication as a readout of craniofacial tissue interactions. The global hypothesis is that 
perturbation of gene expression during adult craniofacial tissue regeneration has functional 
outcomes that extend beyond the immediately dysmorphic structures. It was additionally 
hypothesized that: (1) genes differentially expressed at early time points play unique roles during 
cellular reprogramming and adult muscle regeneration and (2) fundamental changes in dental and 
craniofacial morphology decrease chewing efficiency. 
Zebrafish possess robust regenerative capabilities as demonstrated by the rapid (i.e., 7-10 
day) anatomic and functional regeneration of individual craniofacial muscles following >50% 
surgical resection. Analysis of differentially expressed genes (DEG) at two time points (i.e., 9 and 
18 hours post injury(hpi)) within actively regenerating craniofacial muscle identified over 6000 
candidates that could play a role during craniofacial muscle regeneration. Subsequent clustering 
of these DEG by temporal expression patterns then revealed subsets of genes which were 
transiently upregulated at only the 9hpi (early) or 18hpi (late) time points. Among the early 
expressed genes were known epigenetic regulators including ezh2, prmt5, and prmt7. In vivo 
knockdown experiments revealed that these genes were necessary for both cellular reprogramming 
and anatomic regeneration. This differed from late expressed genes such as fn1a which was 
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necessary for anatomic regeneration but not cellular reprogramming. Also among the early 
expressed genes were twist transcription factors, elements known to affect craniofacial muscle 
development and epithelial to mesenchymal transitions during tumorigenesis. Of the zebrafish 
twist paralogs, only twist3 was necessary for cellular reprogramming and anatomic regeneration 
in adult zebrafish while twist1a, twist1b, and twist2 only affected embryonic muscle development.  
Ellis-van Creveld syndrome (EVC) is a rare genetic condition that affects the craniofacial 
region. However, the etiology of cephalometric differences and the functional outcomes of dental 
and craniofacial dysmorphology are poorly described in the literature. Use of an animal model for 
EVC in which a causative gene ortholog (i.e., Evc2) was conditionally knocked out (cKO) in neural 
crest cells revealed that changes in facial profile advanced with age and were secondary effects of 
a shortened anterior skull base. Further application of our Evc2-cKO model revealed that 
mastication parameters such as bite force and chewing rate were reduced as were molar surface 
area and complexity. No changes in chewing effectiveness suggested that behaviors such as longer 
feeding bouts may effectively compensate for anatomic deficits in the craniofacial region.  
Investigation into the temporal regulation of adult tissue regeneration and gene 
subfunctionalization has led to the identification of multiple pathways that represent potentially 
druggable targets for future regenerative therapies. Assessment and characterization of the 
functional outcomes in states of congenital craniofacial dysmorphology provide insight into form-
function relationships and represent potential metrics by which successful rehabilitation may be 
measured. However, future studies must further elucidate the additional mechanisms (e.g., histone 
modification) underlying tissue regeneration as well as assess adaptation by evaluating chewing 




Chapter 1: Introduction 
 
1.1 Review of Craniofacial Muscle Regeneration 
1.1.1 Extraocular Muscle Regeneration in Adult Zebrafish 
Embryologically and functionally distinct from somitic muscles, craniofacial muscles are 
involved in many orofacial disorders with degenerative, inflammatory, neoplastic, and traumatic 
etiologies [1–3]. Mammalian myonuclei are described as postmitotic and muscle repair is limited 
by both the severity of tissue damage and the paucity of resident stem cells (i.e., satellite cells) 
available for tissue replacement [4–6]. As a result, tissue replacement following volumetric muscle 
loss involves a biomechanically inferior fibrotic mass that fills the tissue defect (i.e., form) but 
critically fails to restore contractile muscle properties (i.e., function) [7,8]. Craniofacial muscle 
regenerative therapies must therefore overcome the body’s innately limited healing capacity while 
simultaneously addressing the unique physiology of muscles within this region.  
 Zebrafish are an excellent model for studying regeneration due to their ability to robustly 
repair tissues (e.g., bone, heart, retina, fin) following severe volumetric injuries [9–14]. This 
extensive repair, or rather whole tissue regeneration, also varies from mammalian models in that 
it relies on cellular reprogramming and dedifferentiation. Recent work has identified zebrafish 
extraocular muscles (EOMs) as convenient models for studying both anatomic and functional 
muscle regeneration in the craniofacial region [15]. Following ~50% muscle resection, 
regeneration occurs via the rapid dedifferentiation of residual myocytes into a mesenchymal-like 
cell pool that undergoes a proliferative burst then re-differentiates to replace the critical mass of 
lost tissue (Figure 1.1). This dedifferentiation-based process occurs without observable 
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contributions from Pax7-positive satellite cells, completes within a week post injury, and is not 
diminished by multiple rounds of injury.  
Understanding the mechanisms underlying de novo craniofacial muscle regeneration in 
adult organisms is a topic with widespread clinical implications. Though directly relevant to tissue 
engineering strategies, the zebrafish EOM model may also provide insight regarding cell fate 
regulation and subfunctionalization amongst gene paralogs. Regardless, it is an invaluable tool that 





Figure 1.1: Model of EOM Regeneration 
Model of EOM regeneration. Following myectomy, the residual muscle undergoes MMT 
consisting of myocyte reprograming, dedifferentiation, loss of apical cell polarity, and cell cycle 
reentry to become myoblasts. These proliferating progenitor cells migrate to repopulate the 








1. Hall, J. G. Importance of Muscle Movement for Normal Craniofacial Development. J. 
Craniofac. Surg. 21, 1336–1338 (2010). 
2. Laumonier, T. & Menetrey, J. Muscle injuries and strategies for improving their repair. J. 
Exp. Orthop. 3, (2016). 
3. Sartore, S. et al. Fibre types in extraocular muscles: a new myosin isoform in the fast 
fibres. J. Muscle Res. Cell Motil. 8, 161–172 (1987). 
4. Mauro, A. Satellite cell of skeletal muscle fibers. J. Biophys. Biochem. Cytol. 9, 493–495 
(1961). 
5. Snow, M. H. Myogenic cell formation in regenerating rat skeletal muscle injured by 
mincing I. A fine structural study. Anat. Rec. 188, 181–199 (1977). 
6. Schmalbruch, H. & Lewis, D. M. Dynamics of nuclei of muscle fibers and connective 
tissue cells in normal and denervated rat muscles. Muscle and Nerve 23, 617–626 (2000). 
7. Garg, K. et al. Volumetric muscle loss: Persistent functional deficits beyond frank loss of 
tissue. J. Orthop. Res. 33, 40–46 (2015). 
8. Corona, B. T. et al. The promotion of a functional fibrosis in skeletal muscle with 
volumetric muscle loss injury following the transplantation of muscle-ECM. Biomaterials 
34, 3324–3335 (2013). 
9. Geurtzen, K. et al. Mature osteoblasts dedifferentiate in response to traumatic bone injury 
in the zebrafish fin and skull. Development 141, 2225–34 (2014). 
10. Poss, K. D., Wilson, L. G. & Keating, M. T. Heart regeneration in zebrafish. Science (80-
. ). 298, 2188–2190 (2002). 
11. Jopling, C. et al. Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation 
and proliferation. Nature 464, 606–609 (2010). 
12. Thummel, R. et al. Inhibition of zebrafish fin regeneration using in vivo electroporation 
of morpholinos against fgfr1 and msxb. Dev. Dyn. 235, 336–346 (2006). 
13. Thummel, R. et al. Characterization of Müller glia and neuronal progenitors during adult 
zebrafish retinal regeneration. Exp. Eye Res. 87, 433–444 (2008). 
14. Singh, S. P., Holdway, J. E. & Poss, K. D. Regeneration of Amputated Zebrafish Fin 
Rays from De Novo Osteoblasts. Dev. Cell 22, 879–886 (2012). 
15. Saera-Vila, A. et al. Myocyte Dedifferentiation Drives Extraocular Muscle Regeneration 






1.2 Review of Ellis-van Creveld Syndrome (EVC)1 
1.2.1 Background 
First described in 1940, Ellis-van Creveld syndrome (EVC; MIM ID #225500) is a rare, 
recessive congenital disorder that results in a type of disproportionate dwarfism [1]. Affected 
individuals represent approximately 1 in every 60,000–200,000 live births with higher occurrence 
reported in offspring of consanguineous (e.g., first cousin) unions or monotypic populations [2,3]. 
In addition to short stature (Figure 1.2 A), other conspicuous signs of EVC include extra digits 
(i.e., polydactyly), dysmorphic faces, and dental anomalies [4]. While none of these directly confer 
shortened longevity, approximately 60% of patients suffer from underlying cardiac conditions, 
indicating widespread developmental effects. 
Although EVC was known to occur more frequently in certain families and/or communities 
(e.g., the Pennsylvania Amish), several decades passed before the causative gene(s) (i.e., EVC and 
EVC2/LIMBIN) were identified. Mutations in either of these head-to-head genes located on human 
chromosome 4p were found to contribute to EVC and a dominant but phenotypically milder form 
called Weyers acrodental dysostosis (also known as Curry–Hall syndrome, WAD; MIM ID 
#193530)) [3,5]. The primary difference between EVC and WAD is the severity of clinical 
phenotypes and pattern of inheritance. Though mutations in EVC and EVC2 account for the 
majority of the patients, there are still patients that present with EVC symptoms despite no 
mutations in either EVC or EVC2 [6,7]. EVC is an autosomal recessive disorder and is associated 
with a more severe phenotype, specifically heart abnormalities, which are the main cause of 
morbidity. Since EVC and EVC2 share limited homology, EVC and EVC2 were named based on a 
historic timeline of mapping and cloning of causative genes for EVC, and thus they do not form a 
 
1 Published as Louie KW, Mishina Y, Zhang H. 2020. Molecular and Cellular Pathogenesis of Ellis-van Creveld 




gene family. In this manuscript, we use both EVC2 and LIMBIN to describe this gene, because 
pathophysiologic function of this gene was firstly identified as a causative gene of Bovine 
chondrodysplastic dwarfism and named as LIMBIN [8]. 
Animal models of EVC have been critical for providing insight into disease pathogenesis 
(detailed in subsequent sections) [9–11]. The initial observation was from EVC2/LIMBIN mutant 
cattle that developed bovine chondrodysplastic dwarfism (BCD) (Figure 1.2 B and C). Studies of 
mice revealed phenotypes similar to cattle (Figure 1.2 C, E, and F), which is the result of reduced, 
but not eliminated, hedgehog (Hh) signaling. Both EVC and EVC2/LIMBIN proteins have also 
been shown to form a complex at the bottom of primary cilia. This has led to the classification of 
EVC as a ciliopathy or disorder of the primary cilia. Because the management of patients with 
EVC is currently limited to corrective therapy, deepened understanding of disease pathogenesis 
from animal models raises the possibility of targeted therapy and improved clinical outcomes.  
The review highlights lessons in disease etiology learned from mouse models of EVC with 
targeted mutations in the causative genes. We will cover: (Section 1.1.2) molecular biology of 
EVC and EVC2/LIMBIN, (Section 1.1.3) human disease signs, (Section 1.1.4) dysplastic limb 
development, (Section 1.1.5) craniofacial anomalies, (Section 1.1.6) tooth anomalies, (Section 







Figure 1.2: Individuals affected by EVC, LIMBIN mutant cattle, and Evc2/Limbin mutant 
mouse share similar dwarfism. 
(A) A 20-month-old infant affected by EVC syndrome (left) and a 20-month-old infant without 
EVC syndrome (right) © BMJ. The infant with EVC syndrome has un-proportional shortened 
legs. (B) A LIMBIN mutant cattle bears apparent short legs. (C) Evc2/Limbin mutant mice with 
littermate controls exhibit a smaller body size at 5 weeks old. (D) LIMBIN mutant cattle have 
decreased size of growth plate (marked in white arrow) in appendicular bones. (E) The growth 
plate of tibia from Evc2/Limbin mutant mice demonstrate shorter and disorganized structure at 5 
weeks old compared with control mice. Bars indicate 200 um. (F) Tibiae from E18.5 mouse 
embryos were stained with alcian blue for cartilage and alizarin red for bone. Tibiae from 
Evc2/Limbin mutant embryos are shorter than those in control littermates, although body size in 
these two groups are similar at this stage. 
 
 
1.2.2 Primary Cilium, Ciliopathy, and EVC 
Despite longstanding clinical description, it was not until the late 1990s and early 2000s 
that the two causative genes of EVC (i.e., EVC and EVC2/LIMBIN) were successfully mapped in 
human genomes [3,5]. Subsequent molecular studies have demonstrated that both EVC and 
EVC2/LIMBIN locate and play an important role within the primary cilium [9–12] (Figure 1.3 A 
and B). Cilia are rod-shaped microtubule-based surface structures present in nearly all vertebrate 
cells [13]. Cilia can be categorized into primary cilia and motile cilia, the former of which have 
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nine pairs of microtubule doublets and are immotile, and the latter of which have one more pair of 
microtubule doublets in the center of the nine pairs of microtubule doublets and can perform rotary 
movement [13], which is critical for the normal physiology of brain, lung, and sinus [14,15]. 
Different from motile cilia, which are only present in specific cells, primary cilia are present in 
nearly all vertebrate cells and they are critical for various aspects of development, post-
development homeostasis, and diseases [16]. The unique receptor composition within the primary 
cilium makes it an important signaling center in vertebrate cells. Congenital mutations in a series 
of primary ciliary components leads to dysfunction of the primary cilium and results in syndromic 
disorders (termed ciliopathies) in which organogenesis during embryonic and postnatal 
development are affected. Studies in the past 15 years have demonstrated that the primary cilia are 
involved in regulating Hedgehog, G protein-coupled receptors, WNT, receptor tyrosine kinases, 
and transforming growth factor-beta (TGF-beta)/bone morphogenetic protein (BMP) [16]. Of 
these, the regulatory function of the primary cilium in Hedgehog signaling induction is best 
studied. In the absence of the Hedgehog ligand, Hedgehog signaling receptor (i.e., PTCH1) is 
enriched within the primary cilium, whereas Hedgehog signaling effector protein (i.e., 
Smoothened, SMO) is expelled out of the primary cilium [17] (Figure 1.3 D). At this time, 
transcription factor GLI is processed into repressor form for Hedgehog target genes at the ciliary 
base. The binding of the Hedgehog ligand with PTCH1 leads to a conformation change of PTCH1, 
which leads to PTCH1 trafficking out of primary cilium and the accumulation of SMO within the 
primary cilium [17] (Figure 1.3 E). The accumulation of SMO leads to subsequent ciliary 
trafficking and ciliary tip accumulation in a series of Hedgehog signaling components, including 
GLI1, GLI2, GLI3, KIF7, and SUFU [18–20]. Shuttling in and out of the primary cilium leads to 
the processing of GLI proteins into activators, which translocate into the nucleus after trafficking 
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out from the primary cilium and function as activators of Hedgehog signaling responsive genes 
[18] (Figure 1.3 E). EVC and EVC2/LIMBIN form a protein complex with SMO upon induction 
of Hedgehog signaling and this interaction has been demonstrated to be dependent on the primary 
cilium [11,12,21]. Based on these, it would be reasonable to expect that the overexpression of wild 
type Evc and Evc2/Limbin would lead to increased cellular response to Hedgehog ligand. However, 
forced expression of Evc and Evc2/Limbin together in NIH3T3 cells leads to decreased response 
to Hedgehog ligands [11]. Further studies are needed to delineate the mechanism of how forced 
expression of Evc and Evc2/Limbin together leads to decreased response to Hedgehog ligands. 
Biochemical studies indicate that both EVC and EVC2/LIMBIN are N-terminal anchored 
membrane proteins that form a protein complex and are mutually required for ciliary localization 
[22]. While EVC and EVC2/LIMBIN share limited homology, the loss of function of one abolishes 
ciliary localization of the other, which can explain why clinical signs caused by mutations in EVC 
resemble those caused by mutations in EVC2/LIMBIN [11,22]. Within primary cilia, the EVC-
EVC2/LIMBIN complex is located in a specific zone between the transition zone and Inversin 
zone [21] as shown in Figure 1.3 D and E. The specific zone in cilia is therefore named the EVC 
zone. Correct localization into the primary cilium and correct sub-ciliary localization within the 
primary cilium is critical for the function of EVC and EVC2/LIMBIN. Compared to EVC, the 
molecular biology of EVC2/LIMBIN is better studied. There are two major consensus sequences 
located at the C-terminus of EVC2/LIMBIN that are required for its precise localization: the FV 
domain and W sequence (Figure 1.3 C). The FV domain, containing two amino acids, 
phenylalanine, and valine, is located at the C terminal of EVC2/LIMBIN. It is responsible for 
locating EVC2/LIMBIN to the primary cilium and is conserved in almost all vertebrate, including 
fish. A disrupted FV domain leads to failed ciliary EVC2/LIMBIN localization and attenuated 
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response to the induction of Hedgehog signaling. The W sequence was initially identified in 
Weyers acrodental dysostosis, a phenotypically milder form of EVC. A functional FV domain but 
abolished W domain leads to a dominant negative form of EVC2/LIMBIN, which still locates into 
primary cilium but has aberrant sub-ciliary localization (i.e., generalized as opposed to restricted 
to the bottom of cilium) (Figure 1.3 G) [21,23]. Consequently, cellular response to Hedgehog 
signaling induction is attenuated to a lesser degree in cells with the abolished FV domain. 
Mechanistic studies indicate that protein EFCAB7 is responsible for tethering the EVC-
EVC2/LIMBIN complex to the EVC zone within primary cilium via interaction with EVC2′s W 
domain [21]. These studies provide insight into the genetics of EVC, particularly regarding 
mutations identified in EVC2/LIMBIN (Figure 1.3 F). In the majority of EVC patients with 
EVC2/LIMBIN mutations, disease is inherited in a recessive manner and failed ciliary 
EVC2/LIMBIN localization can be attributed to non-functional FV caused by frame shift mutation 
[6]. Dissimilarly, Weyers acrodental dysostosis has a dominant inheritance pattern, a functional 
FV domain, a non-functional W domain, and a dominant negative form of the mutated 
EVC2/LIMBIN protein [4,6] (Figure 1.3 G). In contrast to studies on EVC2/LIMBIN, there are 
almost no biochemical studies on EVC despite many frame shift mutations identified in human 
patients [6]. This similarity suggests that, like EVC2/LIMBIN, the C-terminus of EVC may 
likewise be critical for the function of the EVC-EVC2/LIMBIN complex. Experimental evidence 
is warranted to prove the importance of the C terminal in EVC. In addition to the frame shift 
mutations, there are also missense mutations identified in EVC and EVC2 in human affected by 
EVC [6]. All mutations identified in EVC and EVC2/LIMBIN, except those in the W domain of 
EVC2/LIMBIN, are recessive alleles. There is a recessive allele that is linked to less severe signs 
in affected individuals [24], prompting an idea that this recessive allele may be hypomorphic. 
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However, it is difficult to make a judgement if any EVC or EVC2/LIMBIN mutations are 
hypomorphic alleles through the severity of presented signs because 1) the genetic background in 
human population is complex; 2) the population size of individuals affected by EVC is very small. 
Mechanistic studies at molecular levels are needed to determine if mutant alleles are hypomorphic. 
It should be noted that multiple lines of evidence suggest that EVC or EVC2/LIMBIN loss 
of function only partially compromises Hedgehog signaling [9,11,25]. This critical detail is 
supported by both in vitro molecular studies and in vivo phenotypic studies. For example, 
Evc2/Limbin mutant mouse embryonic fibroblast (MEF) or primary chondrocytes show two thirds 
of Gli1 or Ptch1 expression levels in comparison to control cells [9,11]. This is further supported 
by comparisons of mRNA levels of Gli1 and Ptch1 between multiple tissues between control and 
Evc or Evc2/Limbin mutant mice [10,25]. As pointed out by Zhang et al. [25], the partially 
compromised, instead of largely attenuated, Hedgehog signaling is the likely reason leading to 
normal lips, palate and neural tube development in humans affected by EVC and in Evc or 
Evc2/Limbin mutant mice [9,10,25], as summarized in Table 1.1. On the other hand, simply 
believing that the partially compromised Hedgehog signaling is the reason leading to the abnormal 
phenotypes in mutant mice or signs in humans may lead to an inaccurate understanding of the 
pathological mechanism. On the other hand, it is still not known if as ciliary components, EVC 
and EVC2/LIMBIN are involved in the ciliary regulation of other signaling pathways, and how 







Figure 1.3: Primary cilium, EVC and EVC2/LIMBIN proteins, and the mechanism of 
EVC-EVC2/LIMBIN in regulating Hedgehog signaling within the primary cilium. 
Diagrams of the motile cilium (A) and the primary cilium (B) are shown. CB, cilium base; CP, 
cilium pocket. (C). Structures of the EVC and the EVC2/LIMBIN are shown. The EVC and 
EVC2/LIMBIN are N terminal anchored proteins. Blue box in the EVC and orange box in the 
EVC2/LIMBIN indicate domains for interaction with each other. Green box indicates the domain 
for the ciliary localization of the EVC2/LIMBIN and the yellow box indicates the domain for 
localization of the EVC2/LIMBIN at the EVC zone. Numbers indicate the numbers of amino 
acids in each protein. (D) EVC-EVC2/LIMBIN complexes are localized at the bottom of cilia by 
tethering to EFCAB7 through the W domain in EVC2/LIMBIN. In the absence of Hedgehog 
ligand, PTCH1 resides within the primary cilium, and GLI proteins are processed to the repressor 
form (GLI-R) at the centrosome. (E) In the presence of Hedgehog ligand, binding of the ligands 
with PTCH1 leads to exclusion of PTCH1 out of the primary cilium, which allows SMO to enter 
the primary cilium. Within the primary cilium, SMO interacts with EVC-EVC2/LIMBIN at the 
bottom of the primary cilium, which allows GLI trafficking into the primary cilium and 
accumulation at the tip of the primary cilium. After entering the primary cilium, GLI are 
processed to the activator form (GLI-A). GLI activators exit the primary cilium and translocate 
into the nucleus to activate Hedgehog responsive genes. (F) EVC or EVC2/LIMBIN loss of 
function leads to absence of EVC-EVC2/LIMBIN complexes within the primary cilium. When 
Hedgehog signaling is activated, SMO still moves into the primary cilium, but without EVC-
EVC2/LIMBIN complexes, SMO cannot lead to full activation of GLI. (G) In Weyers form of 
mutant cells, EVC-EVC2/LIMBIN complexes cannot be restricted at the bottom of primary 
cilium due to no interactions with EFCAB7 caused by loss of the W domain in EVC2/LIMBIN, 






Table 1.1: Clinical signs of EVC and phenotypes of Evc, Evc2/Limbin mutant mice, and 
mice with Hedgehog signaling defects. 
 
 
1.2.3 Overview of Human Signs 
Classic signs associated with EVC include polydactyly, congenital morbus cordis or heart 
disease, chondrodysplasia, and ectodermal dysplasia [1]. However, this tetrad is not present in all 
cases and there are reported degrees of severity [4]. Patients require an interdisciplinary treatment 
strategy due to symptom variability and prognosis which is ultimately dependent upon the extent 
of cardiac anomalies [26–28]. As a result, reports of adult patients with EVC are less common, 
though this may represent a bias towards pediatric diagnosis, based on apparent disease signs (e.g., 
polydactyly and chondrodysplasia) [28,29]. Individuals surviving beyond the tenuous neonatal 
period may live a normal lifespan and tend to have normal emotional and intellectual development, 
though there are reported instances of impairment [30]. 
Polydactyly, or the presence of extra digits, is the most conspicuous sign of EVC at birth 
[1,4]. Hands may have between 6–7 digits with extra fingers always present on the ulnar side (i.e., 
postaxially). Toes, though typically normal in number, may be irregularly aligned; both sets of 
appendages have dysplastic nails due to the associated ectodermal dysplasia. Patients exhibit 












defects in mice 
Limb Short Short (mild) Short Short Short 
Craniofacial Normal Normal Normal Normal Cleft lips, cleft Palate 













include non-functional distal metacarpals. Additional digits can be surgically removed; however, 
this does not improve the “plump” appearance due to the underlying shortened bones. 
Congenital heart disease is present in 50–60% of EVC patients and is the most significant 
cause of morbidity [4,26–28,31]. Septal defects range in severity with the most severe being cor 
biloculare or a two chambered heart. Venous anomalies concurrent with either atrial septal defects 
(ASD) or ventricular septal defects (VSD) may contribute to death via pulmonary hypotension. 
Accurate diagnosis and management of cardiac abnormalities are therefore necessary for improved 
disease prognosis. 
Chondrodysplasias are disorders of bone growth that manifest as shortened stature. Though 
potentially non-apparent at birth, disproportionate dwarfism in patients with EVC is the result of 
long bones that are more shortened at their distal ends [1,32,33]. Patients have a normal length 
torso but dysplastic primary ossification centers in the paired bones of the arms and legs as well 
as the digits. Shortened ribs also result in a small chest with a keel-like breastbone that may not 
allow for proper lung expansion [31]. Musculoskeletal problems, such as genu valgum (knock 
knee) or talipes equinovarus (club foot), may restrict mobility and require orthopedic intervention 
(e.g., surgery or casting) to correct [4,33]. Interphalangeal ankylosis, most often seen in the distal 
metacarpals, may limit dexterity necessitating lifestyle adaptation and/or corrective surgery. 
Ectodermal dysplasia affects ectodermal derived tissues, such as the hair, skin, nails, and 
teeth. Compared to other types of ectodermal dysplasia, hair and skin abnormalities are mild in 
EVC patients and occur in only about 1/3 of cases [4,34]. As previously mentioned, nails of both 
the hands and feet of patients with EVC are malformed with those of the hands, and especially 
supernumerary digits, being more affected. However, all patients with EVC have a dental 
phenotype that includes hypoplastic enamel, congenitally missing teeth (i.e., hypodontia), 
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abnormally shaped teeth (e.g., taurodontism or bulbous teeth), and premature eruption and 
exfoliation [28,35,36]. Abnormal craniofacial morphology may not be apparent at birth but 
includes a trend towards mandibular prognathism, maxillary deficiency, skeletal open bite, and 
prominent frontal bossing that gives patients a concave-shaped lateral profile. While not at an 
inherently increased risk of caries, the loss of oral function often requires extensive prosthodontic 
rehabilitation (e.g., dentures and implants) starting from a young age [37,38]. Depending on the 
severity of the craniofacial phenotype, patients with EVC may also benefit from treatment by 
speech–language pathologists. 
In addition to the classic signs of EVC, less common findings include genital abnormalities 
and strabismus [2,33]. Abnormal urethral location (i.e., hypospadias) and undescended testicles 
(i.e., cryptorchidism) in males is rare, though the former is common in other forms of ectodermal 
dysplasia. Strabismus, a vision condition characterized by the misalignment of the eyes, is due to 
problems associated with the muscles that move the eyes (i.e., extraocular muscles). These muscles 
develop with influence from cranial neural crest cells, thereby suggesting an expanded role of 
EVC2/LIMBIN in the craniofacial region (see Section 5: Craniofacial Phenotype) [39]. Both 
genital and eye muscle abnormalities are non-life threatening and may be corrected with surgery. 
 
 
1.2.4  Limb Phenotypes 
Dwarfism or shortened stature is one of the most typical symptoms present in patients with 
EVC. Adult patients with EVC usually fall into the height range of 110cm to 155cm (−2 to −4.5 
standard deviation scores) [40]. However, growth hormone deficiency is not consistently observed 
in these patients and growth hormone treatment in pediatric patients does not achieve consistent 
efficacy [40]. This suggests that dwarfism in patients with EVC is not likely due to deficiency or 
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abnormal growth hormone levels. Instead, dwarfism in EVC is mainly characterized by the 
disproportional distal shortening of arms and legs, whereas the trunk size of patients remains 
unchanged [1]. The pathological mechanism leading to the dwarfism in patients with EVC 
therefore lies in abnormal appendicular bone development. 
Appendicular bone elongation during development occurs through endochondral 
ossification, a process in which chondrocyte proliferation and maturation in cartilage play vital 
roles in determining the final length of bones in the arms and legs [41,42]. Appendicular bone 
development is initiated from the condensation of mesenchymal cells and subsequent 
differentiation to chondrocytes [41]. Chondrocytes then undergo a series of proliferation and 
maturation steps, which allows for the formation of the primordial cartilage of appendicular bone. 
Chondrocyte proliferation and maturation are well orchestrated by a series of locally produced 
factors that ensure the correct length and shape of each skeletal element. Previous studies have 
demonstrated that many signaling pathways play important roles in regulating chondrocyte 
proliferation and maturation (Figure 1.4 A). For example, Fibroblast Growth Factor (FGF) 
signaling, mediated by FGF18 produced in the perichondrium, is involved in this regulatory 
network [43–45]. In the growth plate, FGF signaling inhibits chondrocyte proliferation through 
STAT1-mediated p21 expression and inhibits chondrocyte differentiation through MEK/PERK-
mediated signaling [44,45]. Additionally, Indian Hedgehog and parathyroid hormone-related 
protein (PTHrP) signaling also play important roles in the regulation of chondrocyte proliferation, 
differentiation, and maturation. Indian Hedgehog is expressed by the pre-hypertrophic 
chondrocytes and stimulates PTHrP expression in chondrocytes at the distal end of the growth 
plate. PTHrP promotes chondrocyte proliferation and prevents them from directly progressing to 
pre-hypertrophic differentiation [46]. Once proliferating chondrocytes are far away enough from 
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the source of PTHrP (i.e., chondrocytes at the distal end of the growth plate), they differentiate 
into pre-hypertrophic chondrocytes, start expressing Indian Hedgehog, and then further mature 
into hypertrophic chondrocyte cells [41,47] (Figure 1.4 A). 
Compromised cellular response to Hedgehog signaling seen in Evc or Evc2/Limbin loss of 
function mouse models has been originally speculated as the pathological mechanism leading to 
dwarfism in EVC [10,11,21]. Based on the current understanding, decreased Hedgehog/PTHrP 
signaling in the chondrocyte should lead to subsequently decreased proliferation and abnormal 
maturation of chondrocytes in cartilage of the appendicular skeleton. Indeed, studies using mouse 
models confirmed the decreased Hedgehog signaling and PTHrP expression in the growth plate of 
both Evc and Evc2/Limbin mutant mice. However, Zhang et al. [25] presented surprising evidence 
suggesting that compromised Hedgehog signaling is not the reason leading to dwarfism; 
chondrocyte specific deletion of Evc2/Limbin leads to very mild dwarfism at embryonic day E18.5 
and leads to no dwarfism at postnatal day P21 [25]. 
Subsequent studies of abnormal signaling in the Evc2/Limbin mutant growth plate by 
Zhang et al. [25] implicate an elevated FGF secretion from the perichondrium as a critical 
contributor to the dwarf phenotype (Figure 1.4 B) [25]. Chondrocyte-specific (note: non-
perichondrium) deletion of Evc2/Limbin results in a mild dwarf phenotype despite compromised 
Hedgehog signaling along with unaffected FGF signaling at both embryonic and postnatal stages. 
On the other hand, concurrent Evc2/Limbin deletion in both chondrocytes and perichondrium 
results in a severe dwarfism with compromised Hedgehog signaling and elevated FGF signaling 
at embryonic and postnatal stages [25] suggesting that increased FGF18 production in the mutant 
perichondrium is critical to inhibit chondrocyte proliferation and leads to dwarfism (Figure 1.4 B, 
red arrow). Though it is still unresolved how Evc2/Limbin loss of function within the 
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perichondrium leads to elevated FGF18 expression, the studies from Zhang et al. [25] highly 
suggest that elevated FGF signaling is a potential druggable target for dwarfism in patients with 
EVC [25]. Elevated FGF signaling in the growth plate is the pathological mechanism leading to 
another form of dwarfism (i.e., achondroplasia) and a soluble form of FGFR3 (sFGFR3) was 
recently evaluated in a clinical trial for treating this dwarfism [48]. The similar pathological 
mechanism for dwarfism in achondroplasia and EVC suggests that sFGFR3 may be a viable 




Figure 1.4: Elevated FGF signaling is critical for the pathogenesis of the dwarfism 
developed in EVC.  
(A) In control growth plate, both Hedgehog signaling (yellow-green feedback loop) and FGF 
signaling (red) work on chondrocytes to ensure regulated proliferation and maturation. (B) In 
Evc2/Limbin mutant growth plate, moderately decreased Hedgehog signaling due to Evc2/Limbin 
loss of function within only chondrocytes moderately contributes to the pathogenesis of 
dwarfism, whereas elevated FGF signaling due to loss of Evc2/Limbin within perichondrium 
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critically contributes the pathogenesis of the dwarfism. Green, resting chondrocytes; gold sand, 
proliferating chondrocytes; aqua, hypertrophic chondrocytes, IHH, Indian Hedgehog ligand. 
 
 
1.2.5 Craniofacial Phenotype 
The concave facial profile seen in patients with EVC suggests morphologic differences in 
the midfacial and skull base regions. Mice highly express both Evc and Evc2/Limbin within these 
areas and Evc and Evc2/Limbin deficient mice show craniofacial phenotypes that recapitulate 
human signs [9–11,49–51]. Evc is expressed in the maxillary and mandibular processes from 
embryonic day E11.5 and detectable in the nasal septum at E15.5 [10]. Evc2/Limbin at E15.5 is 
similarly expressed within the mandible and maxilla as well as in the nasal, premaxilla, cranial 
sutures, and spheno-occipital synchondrosis [8,50]. Though no obvious craniofacial differences 
are discernible at embryonic time points, the structures listed above collectively represent 
cartilage-derived elements of the braincase and facial skeleton (i.e., neurocranium and 
viscerocranium), thereby providing insight into postnatal disease pathogenesis. 
Many elements within the craniofacial region, specifically the neurocranium and 
viscerocranium, arise from neural crest cells (NCCs), a special population of cells that maintain 
their identity despite divergence from the ectoderm in early gastrulation [52]. Abnormal 
craniofacial morphology (i.e., midfacial depression) in both global and NCC-specific Evc2/Limbin 
deficient mice (referred to as Evc2/Limbin-KO and Evc2/Limbin-cKO, respectively) is a 
consequence of abnormalities within NCC-derived elements of the neurocranium and 
viscerocranium [50,51,53,54]. As with patients with EVC, midfacial depression or retrusion in 
mice becomes more pronounced with age and can be attributed to positional differences between 
the nasal bone, jaws, and cranial base [51,53]. Though this suggests a critical, NCC-specific role 
for Evc2/Limbin in determining postnatal craniofacial morphology, it does not indicate which 
structure (i.e., maxilla vs. skull base) is responsible for the resultant phenotype. 
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Cephalometric analysis is required to determine the etiology (i.e., maxilla vs. skull base 
deficiency) of midfacial retrusion in patients with EVC. Although such analyses are rare within 
the literature, findings from different Evc2/Limbin-cKO mouse models implicate the role of 
Evc2/Limbin in the anterior skull base (Figure 1.5 A and C). Though both Cre “drivers” (i.e., Wnt1-
Cre and P0-Cre) used to create Evc2/Limbin-cKO mice are expressed throughout the jaws and 
facial skeleton, Wnt1-Cre-based recombination efficiency in the anterior skull base is much higher 
(100% vs. 50% for Wnt1-Cre and P0-Cre, respectively), results in worse midfacial deficiency, and 
causes greater skull base defects that in their Evc2/Limbin-P0-cKO counterparts [53]. This is 
significant as the skull base is a midline structure that connects the posterior of the head with the 
facial region and aberrant skull base morphology has been found to contribute to other syndromic 
facies. 
A part of the neurocranium, the skull base is formed by endochondral ossification and 
consists of three segments connected by two growth plates or synchondroses, all mirrored and 
fused across the midline. Though skull base expression of Evc and Evc2/Limbin is lower than in 
the facial skeleton, all animal models of EVC (i.e., Evc-KO, Evc2/Limbin-KO, and Evc2/Limbin-
cKO) have discernible differences in skull base size, shape, and bone quality [11,49,50,53]. 
Despite differences in facial gross morphologies, sizes and shapes of calvarial bones (nasal, frontal 
and parietal) are comparable between mutants and controls (Figure 1.5 B). Morphometric 
differences in Evc2/Limbin-cKO mice were most apparent in the anterior vs. posterior skull base 
(i.e., presphenoid and basisphenoid vs. basioccipital) where they, as with Evc-KO mice, also 
showed the premature fusion of the intrasphenoidal synchondrosis (ISS) between these two parts 
[49,53] (Figure 1.5 C). As expected, no differences were seen in the non-NCC-derived 
basioccipital at the posterior skull base (Figure 1.5 C) and spheno-occipital synchondrosis (SOS) 
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remains open in the Evc2/Limbin-cKO. The collective evidence suggests that Evc2/Limbin genes 
affect postnatal craniofacial morphology by maintaining the ISS and allowing for anterior skull 
base elongation. This critically explains why patients with EVC present progressively worsening 




Figure 1.5: A shortened skull base leads to mid-facial defects in Evc2/Limbin mutant mice. 
(A) Surface models of the mid-line regions were generated based on the micro-CT scans of 
controls (green) and Evc2/Limbin mutants (yellow). Two models were then superimposed at the 
occipital bones of the skull. Green and yellow lines are spanning the entire regions of the skull 
bases in control and mutant, respectively; black arrows indicate the intersphenoidal 
synchondrosis (ISS) and the spheno-occipital synchondrosis (SOS) in skull base. (B) Models 
were generated from the skull region containing nasal, frontal and parietal bones from micro-CT 
scans of control and mutant. No apparent defects were observed in Evc2/Limbin mutants in 
comparing to controls. (C) Models were generated from the skull base from micro-CT scans of 
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controls and mutants. Apparent shortened anterior parts of skull bases from Evc2/Limbin mutants 
are observed in comparison to controls, whereas the posterior part of the mutant skull bases 
remains the same length with the controls. Black arrows indicate the ISS and the SOS. 
 
 
1.2.6 Tooth Phenotype 
Embryonic tooth development requires a series of morphological differentiations and the 
interaction between the dental epithelium and mesenchyme. Ameloblasts and odontoblasts arise 
from the dental epithelium and mesenchyme, respectively, and secrete matrix proteins necessary 
for the formation of enamel and dentin. Despite this crosstalk, ameloblast and odontoblasts have 
different developmental origins and, respectively, arise from ectodermal or neural crest cells [55]. 
The recapitulation of human dental abnormalities in animal models has revealed expanded and 
cell-specific roles of Evc or Evc2/Limbin in disease pathogenesis. 
Global disruption of Evc or Evc2/Limbin and NCC-specific disruption of Evc2/Limbin in 
mice all result in a range of dental phenotypes of the likes seen in patients with EVC. This includes 
enamel hypoplasia, hypodontia (i.e., congenitally missing teeth), and progressively abnormal tooth 
morphology (e.g., small, conically shaped, fused, and/or short rooted) [9,10,51,56]. Phenotypic 
similarity between global and NCC-specific Evc2/Limbin deficient mice importantly suggests that 
Evc2/Limbin expression in the NCC-derived dental mesenchyme determines tooth morphology 
and enamel development. This means that tooth and enamel phenotypes seen in patients with EVC 
are secondary results, driven by misexpression in NCC-derived cells. 
 
 
1.2.7 Tracheal Cartilage Phenotypes 
Unlike other symptoms of EVC that become more apparent throughout childhood, airway 
obstruction or collapse is an immediate and life-threatening condition that may have been 
overlooked and underreported for a long time. Neonatal death associated with collapsed airway 
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has been documented in infant patients with EVC. Biopsies indicate hypomorphic tracheal 
cartilage that is unable to support the tracheal epithelia during the initiation of breathing [1]. The 
insufficient cartilaginous support of the airway at laryngeal, tracheal, or bronchi level condition is 
termed laryngotracheobronchomalacia and may also lead to stridor or noisy breathing in infant 
patients with EVC [1]. Similarly, neonatal death was reported in Evc2/Limbin mutant mice [9]. 
Whether the neonatal death is due to defective cartilage structure will be worth investigating. 
 
 
1.2.8 EVC-like disorders in Non-Human Species 
Examples of dwarfism or small stature resulting from a medial or genetic condition are not 
uncommon throughout the animal kingdom. However, while news headlines are dominated by the 
discovery of insular dwarf species and deliberate selection has led to the development of numerous 
toy and true “dwarf” animal varieties, chondrodysplastic cases attributable to mutations in animal 
orthologs (specifically EVC2/LIMBIN) are restricted to two breeds of cattle. However, recent 
comparative studies have the potential to spark interest in the etiology of EVC-like disorders and 
reveal the evolutionary significance of EVC2/LIMBIN in other species. 
The Japanese brown cattle is a horned cattle breed esteemed for its use in beef production, 
known as wagyu. Starting in the late 1980s, calves from a specific region of Japan were born with 
a type of dwarfism (i.e., ateliosis) characterized by disproportionately short limbs and joint 
abnormalities [57]. Termed bovine chondrodysplastic dwarfism (BCD), this unusual phenotype 
was inherited in an autosomal recessive fashion and was later found to be caused by either deletion 
or frameshift mutations in a gene (i.e., LIMBIN) located on chromosome 6 [57,58]. LIMBIN was 
subsequently identified as an ortholog of human EVC2 despite the lessened severity of symptoms 
in bovine vs. human patients [8]. Identification and targeted manipulation of the murine ortholog 
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laid the groundwork for the generation and phenotypic characterization of non-human models of 
EVC (see previous sections) that have been invaluable in our mechanistic understanding of disease 
development. 
A similar form of disproportionate dwarfism in Tyrol grey cattle was reported in the early 
21st century. The Tyrol grey is a horned, dual purpose breed of Austrian and Italian origin 
considered endangered due to its small population (<4000 individuals vs. >20,000 for Japanese 
brown) [59,60]. Affected calves could be traced back to a single ancestor and displayed the 
characteristic small stature and short limbs seen in both Japanese BCD and human EVC examples 
[59]. In addition to growth plate abnormalities in long bones indicative of dysplastic chondrocyte 
function, some Tyrol BCD specimens also displayed acetabular joint laxity, urogenital 
abnormalities, and cardiac defects reminiscent of human patients with EVC [59,61]. However, 
orofacial, ectodermal, and digit findings in these cattle were unremarkable and appendages were 
shortened in a proximal vs. distal manner as indicated by the shortened femur and humerus. 
Though genetic analyses identified an EVC2/LIMBIN mutation (i.e., deletion) at a different 
location from their Japanese counterparts, these cattle provided an animal model of an EVC-like 
disorder and expanded insight into the role of EVC2/LIMBIN in skeletogenesis. 
Penguins are flightless birds that have undergone numerous morphological adaptations 
suited to an aquatic lifestyle. These include modification of the upper appendages into robust, 
flipper-like wings and pronounced shortening of femoral and lower extremity length, 
characteristics that are superficially like those seen in patients with EVC (see previous sections). 
Genetic analysis of two penguin species (i.e., Pygoscelis adeliae and P. forsteri) surprisingly 
revealed five penguin-specific amino acid changes in EVC2/LIMBIN, the highest amongst all 
analyzed limb-related genes [62]. An additional amino acid change was seen in the penguin EVC 
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ortholog. These results suggest important evolutionary roles of EVC and EVC2/LIMBIN orthologs 




It has been 80 years since the first report of EVC, 13 years since the report of Evc mutant 
mice, and 5 or 8 years since two independent reports of two Evc2/Limbin mutant mouse models. 
Within this short time, genetic mouse models have allowed great insight regarding the 
pathogenesis of EVC, expanded both breadth and depth of knowledge, and provided potential 
insight into therapeutic solutions for different aspects of EVC. Beyond patient care, Evc2/Limbin 
mutant mice have become a precious genetic tool for propelling our current understanding in 
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1.3 Hypotheses and Aims 
There is a clinical need to restore craniofacial tissues affected by disorders of traumatic 
and/or congenital etiology. Effective therapeutic approaches within this specialized area require 
both anatomic regeneration and the effective restoration of function. Regardless of etiology, 
adaptation represents a crucial corrective mechanism necessary for functional restoration and, 
ultimately, the maintenance of life. The work in this dissertation attempts to identify mechanisms 
underlying the regeneration while simultaneously elucidating oral function and adaptation using 
mastication as a readout of craniofacial tissue interactions.  
 
Global Hypothesis: Perturbation of gene expression during adult craniofacial tissue regeneration 
has functional outcomes that extend beyond the dysmorphic structures. 
 
Hypothesis 1: Genes differentially expressed at early time points play unique roles during 
myocyte reprogramming and adult muscle regeneration. 
Aim 1: Utilize RNA-seq to identify candidate genes and pathways that affect myocyte 
reprogramming and craniofacial muscle regeneration in a model with robust regenerative 
capacity (i.e., zebrafish). Phenotypic screening following gene knockdown will then be 
used to assess the necessity of identified targets at different points (e.g., early vs. late) 
during the muscle regeneration process. Gene paralog subfunctionalization and key 
differences between adult tissue regeneration and embryogenesis will then be investigated 






Hypothesis 2: Fundamental changes in dental and craniofacial morphology decrease 
chewing efficiency. 
Aim 2: Characterize craniofacial and dental morphology in an animal model of a human 
genetic disorder (i.e., Ellis-van Creveld syndrome). After establishing fundamental 
changes in craniofacial architecture (e.g., skull base, jaws, and teeth), chewing motions and 
efficiency will then be used as a readout of complex tissue interactions. Changes in 
functional parameters (e.g., bite force, chewing rate, and efficiency) will then be used to 




1.4 Summary and Organization 
In Chapter 2, a high throughput approach is used to identify genes and pathways that 
regulate the muscle-to-mesenchymal transition (MMT) observed in myocytes following a 
volumetric muscle loss injury. Chapter 3 address the unique role of a specific gene paralog (i.e., 
twist3) during regeneration but not embryonic muscle development. Chapter 4 marks the transition 
to Aim 2 and presents a detailed craniofacial characterization of an animal model of a human 
genetic disorder (i.e., EVC) at different stages of maturation. Chapter 5 then examines dental 
morphology in the same animal model and evaluates the effect of changes on chewing 
performance.  Chapter 6 finally summarizes the key findings of this body of work while discussing 





Chapter 2: Regulation of Craniofacial Muscle Regeneration2 
 
2.1 Background 
The goal of regenerative medicine is to replace lost tissue with fully functional regenerated 
tissue following trauma or disease. Given their highly specialized structure and function, skeletal 
muscles are particularly prone to tissue loss following disease or injury, with devastating effects 
on function and quality of life [1,2] Although humans do not have extensive muscle regeneration 
capabilities that persist beyond the embryonic stage, tissue regeneration is observed in other 
vertebrate lineages and has been well studied in both amphibian and piscine models [3–5]. 
Regeneration of lost muscle requires the generation of an adequate number of myocytes to 
match the lost tissue and provide replacement function. Accumulation of such a regenerative cell 
mass can occur via proliferative expansion of resident tissue stem cells (i.e., satellite cells; [6,7]), 
recruitment of cells from outside the damaged tissue area, or dedifferentiation of residual cells into 
progenitor cells capable of robust proliferation and redifferentiation [8,9]. Blastema formation is 
observed in both urodele amphibian leg regeneration models and fish fin regeneration models 
[10,11] and appears to utilize all three regenerative pathways [5]. On the other hand, regeneration 
of zebrafish retina, bone, cartilage, heart, liver, and extraocular muscles (EOMs) primarily utilizes 
dedifferentiation of residual cells [8,9,12–15]. The ability to reprogram “post-mitotic” cells into 
 
2 Published as Louie KW, Saera-Vila A, Kish PE, Colacino JA, Kahana A. 2017. Temporally 
distinct transcriptional regulation of myocyte dedifferentiation and Myofiber growth during 




dedifferentiated proliferating progenitor cells represents a particularly potent approach to adult 
tissue regeneration that circumvents the limitations of stem cell-based techniques [16]. 
Zebrafish EOMs regenerate very rapidly following tissue loss, with myocyte 
reprogramming leading to myoblast proliferation by 20 hours post injury (hpi), anatomic muscle 
regeneration within 5-7 days post injury (dpi), and functional recovery within 8-10 dpi [9]. In order 
to understand the biological events that lead to reprogramming a highly-specialized cell such as a 
“post-mitotic” multinucleated syncytial myocyte, we focused on the transcriptional events that 
occur at time points (9 and 18 hpi) ending just prior to cell cycle reentry by dedifferentiated 
myoblasts seen at 20 hpi. Aided by the relatively homogenous population of dedifferentiating cells 
and utilizing these pre-proliferative time points, we performed a comprehensive transcriptome 
analysis. We were particularly interested in the broad, network-like interactions expected to occur 
within the dynamic biological landscape of reprogramming cells [9,17,18]. 
We report that following a partial myectomy, genes encoding muscle differentiation and 
morphogenic programs are downregulated over time. At the same time, cellular metabolism is 
rewired to accommodate the new needs, while new protein synthesis, along with lysosomal. and 
ubiquitin ligated proteolysis, is upregulated to reshape the cellular proteome. Programs related to 
DNA replication, repair, and chromosome condensation are similarly upregulated and prepare the 
cell to reenter the cell cycle. The rapid activation of epigenetic regulators of transcription likely 
reflects the genomic regulatory changes driving myocyte dedifferentiation. Based on this 
functional analysis, we formulated and tested the hypothesis that early-activated genes would be 
important for the early events of myocyte cellular reprogramming and dedifferentiation, while late-
activated genes would regulate the later anatomic regeneration of the muscle but would not affect 
the initial reprogramming events. The results of our in vivo experiments reveal that myocyte 
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dedifferentiation appears to depend on transcriptional and epigenetic regulation, with key roles for 
early activated genes such as the Polycomb group factors ezh2 and suz12a. On the other hand, 
late-activated genes, such as fn1 (encoding fibronectin - an extracellular matrix protein involved 
in cell migration), are not required for cell reprogramming yet are necessary for tissue 
growth/elongation. These separate processes, and their distinct regulatory networks, provide 
critical insights into the regenerative process and could provide differential targets for harnessing 
de novo tissue regeneration therapeutically. 
 
 
2.2 Materials and Methods 
2.2.1 Zebrafish (Danio rerio) Rearing and Surgery 
All animal work was performed in compliance with the Association for Research in Vision 
and Ophthalmology Statement for the Use of Animals in Ophthalmic and Vision Research and 
approved by the University of Michigan Committee on the Use and Care of Animals, protocol 
06034. Sexually mature adult (4–18 months of age) wild-type and transgenic (α-actin::EGFP) 
zebrafish were spawned in our fish facility and raised according to standard protocol at 28°C with 
a 14-h light:10-h dark cycle. 
Adult zebrafish were anesthetized using 0.05% tricaine methanosulfate (Tricaine-S; 
Western Chemical, Ferndale, WA) and approximately 50% of the lateral rectus (LR) muscle was 
surgically removed [9]. The amount of muscle remaining after surgery (46.77 ± 4.8%, average ± 





2.2.2 RNA Isolation and Sequencing 
Zebrafish heads were decalcified for 2-3 days in a citrate-buffered (pH 5.6) solution 
containing 10% ethylenediamine-tetraacetic acid (EDTA; Thermo Fisher Scientific, Waltham, 
MA) saturated with ammonium sulfate (Promega, Madison, WI) to preserve RNA quality [19]. 
Specimens were directly placed in Shandon M-1 Embedding Matrix (Thermo Fisher Scientific, 
Waltham, MA) frozen on dry ice and coronal frozen sections (16 μm, cryostat temperature -35 to 
-40°C (CM3050S disposable blade cryostat; Leica Microsystems Inc., Buffalo Grove, IL)) were 
placed onto PEN-membrane framed slides (Leica, PN 11505151) and stored at -80ºC. Slides were 
washed and dehydrated (1 min 70% EtOH, 30 sec RNAse-free water, 30 sec 70% EtOH, 2 x 1 min 
100% EtOH). LR muscle tissue was dissected from frozen sections using laser micro-dissection 
(LMD7000; Leica Microsystems Inc., Buffalo Grove, IL). Micro-dissected tissue was collected in 
30 µL aliquots of RLT buffer (Qiagen, Valencia, CA) with 2-mercaptoethanol added (10 µL/mL).  
Pooled aliqouts from several dissected slides had areas that ranged from 27 to 71 million µm2 per 
sample. RNA was isolated in a fixed volume of 1 mL of TRIzol (Invitrogen, Inc., Carlsbad, CA) 
and the manufacturer’s protocol was followed except for the addition of 0.2 mL of dH2O per mL 
of Trizol. Phase separation after chloroform addition was performed using phase lock gel tubes - 
Heavy 2 mL (5-Prime, Gaithersburg, MD). The RNA was further purified on microcolumns with 
DNAse treatment (ReliaPrep RNA Tissue Miniprep System, Promega, Madison WI) after addition 
of an equal volume of 100% EtOH to the Trizol aqueous layer and application to the column.  
Elution was with 15 µL RNAase free water. 
RNA quantity was assessed using a Nanodrop spectrophotometer (Thermo Fisher 
Scientific, Waltham, MA) and both RNA quality and quantity were reassessed using an Agilent 
2200 TapeStation (Agilent Technologies, Santa Clara, CA). Only samples with RIN’s greater than 
7 were further used for RNA-sequencing. Illumina's TruSeq Stranded mRNA Library Prep Kit and 
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0.1 - 4 µg total mRNA from pooled purified RNA samples were used for performing ribosomal-
depletion (Ribo-Zero Gold rRNA Removal Kit, Illumina) and library preparation. 
Sequencing was performed by the UM DNA Sequencing Core, using an Illumina Hi-Seq 
(50-cycle, single end read) platform (Illumina, Inc., San Diego, CA). 
 
2.2.3 Transcriptome Assembly and Differentially Expressed Gene Identification 
The sequencing reads files were concatenated into a single fastq file for each sample. The 
quality of the sequencing reads was assessed using FastQC v0.11.3 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). The Tuxedo Suite package was used 
for alignment, differential expression analysis, and post-analysis diagnostics [20–22]. Briefly, all 
filtered reads were mapped to the reference genome followed by the transcriptome (GRCz10) 
using TopHat v2.0.13 and Bowtie v2.2.1. The default parameter settings for alignment were used, 
with the exception of: “--b2-very-sensitive” and “--max-intron-length” of 400 kbs as described 
previously [23]. Novel transcript discovery was not performed, employing “--no-coverage-search” 
and “--no-novel-juncs” to limit the read mapping to known transcripts. Cufflinks/CuffDiff v2.2.1 
were used for expression quantitation and differential expression analysis, using NCBI GRCz10.fa 
as the reference genome sequence and NCBI GRCz10.gtf as the reference transcriptome 
annotation. For this analysis, the following parameters were used: “--multi-read-correct” to adjust 
expression calculations for reads that map in more than one locus, as well as “--compatible-hits-
norm” and “--upper-quartile –norm” for normalization of expression values. Locally developed 
scripts were used to identify differentially expressed genes (DEG) based on three criteria: test 
status = “OK”, FDR < 0.05, and fold change ≥ 1.5. Genes and isoforms were annotated using 




2.2.4 Clustering and Gene Set Analysis 
Default parameter settings of the R package “cummeRbund” v2.14.0, part of the Tuxedo 
Suite package, were used to perform hierarchical clustering of the results (csDendro function with 
the “replicates=T” option;[24]).  
Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway and Gene ontology (GO) 
term analyses of the whole data set of DEG were performed using the “Generally Acceptable Gene 
set Enrichment” (GAGE v.2.22.0) package implemented in R [25,26]. Briefly, default parameter 
settings were used for comparisons of log-scaled gene set expression data between different time 
points (gage function with the options: compare=unpaired, q value < 0.1). Gene sets were derived 
through Bioconductor (www.bioconductor.org) and compiled using Entrez Gene IDs, mapping 
information, and gene set names contained in GAGE v2.22.0 and other actively maintained 
annotation packages (go.db v3.2.2 and kegg.db v3.2.2). The R package “pathview” v.1.12.0 was 
used to visualize gene set expression data in the context of functional pathways [27]. Expression 
data was rendered over pathway maps (pathview function with default parameters) derived from 
KEGG and compiled using KEGGgraph v1.30.0 [28]. 
CummeRbund was used to perform K-means (csCluster and csClusterPlot functions) 
clustering analyses setting the number of clusters from 3 to 30. The K-means analysis of 18 clusters 
was selected following two criteria: 1) maximize the number of clusters with new expression 
profiles; and 2) minimize the number of clusters that resulted from a simple division of a previous 
cluster into two new ones with the same expression profile. Thus, cluster number 8 (Figure 2.4 E) 
appeared in the analysis of only 4 clusters while cluster 15 (Figure 2.4 H) did not appear until the 
number of clusters was set to 18, and did not change in the following analyses (number of clusters 
set from 19 to 30). Locally developed scripts were used to track the cluster of each gene from one 




2.2.5 Morpholino Oligonucleotide Injection 
Microinjection and electroporation of morpholino oligonucleotides (MOs; Gene-Tools, 
LLC, Philomath, OR) was used as described for knockdown experiments in adult zebrafish [31–
33]. Briefly, lissamine-tagged MOs (~0.2 μL, 1mM in nuclease-free H2O) were directly 
microinjected into the LR muscle followed by electroporation (6 to 10 pulses at 48 V/cm, BTX 
ECM830 electroporator; Harvard Apparatus, Holliston, MA). Microinjections were performed 3 
hours prior to LR injury, and MO uptake was confirmed via lissamine fluorescence prior to 
myectomy. MOs were designed to target the 5’-UTR of respective mRNAs (translational blocking 
MOs), and were compared to a standard control MO (CON) targeting a human beta-globin intron 
mutation. When possible, previously published MOs were utilized (Table 2.1). For all others, MO 
sequence design was performed as a service by Gene Tools. All MOs were injected at the same 
concentration, and all experiments were performed using 5 fish per experimental group per time 




Table 2.1: Sequence of the morpholino antisense oligonucleotides (MOs). 
 
 
 Sequence Reference 
ezh2 5’-CGATTTCCTCCCGGTCAATCCCATG 
[34] 
fn1a  5’-TTTTTTCACAGGTGCGATTGAACAC [35] 
suz12a 5’-GAGCCATCCTAAAATAGCGTTCGTG [36] 





2.2.6 Specimen Processing and Cell Proliferation Assay 
Zebrafish heads were removed and fixed in 4% paraformaldehyde in PBS (PFA; Sigma-
Aldrich, St. Louis, MO) overnight at 4ºC. Decalcification was performed for 48-h using Morse’s 
solution (45% formic acid in H2O, ACROS Organics, Fair Lawn, NJ; 20% sodium citrate in H2O, 
R&D Systems, Bristol, UK). Fixed and decalcified tissues were cryopreserved with 20% sucrose 
in PBS (ACROS Organics, Fair Lawn, NJ), embedded in OCT (Thermo Fisher Scientific, 
Waltham, MA), and frozen.  
Cellular proliferation was assessed by intra-peritoneal injections of 5-ethynyl-2’-
deoxyuridine (EdU; Invitrogen, Inc., Carlsbad, CA) [38]. Wild-type fish were injected with EdU 
(25 μL, 10 mM in PBS) at 44 h post injury and sacrificed 4 h later (Figure 2.5 A). The injured 
muscles of 4-8 fish per experimental group were evaluated microscopically using transverse frozen 
sections (10 μm) as described previously [9]. EdU+ and total (DAPI) nuclei were counted from 3-
4 non-sequential sections per muscle (more than 30 sections per experiment were analyzed), 
representing approximately 700 total nuclei (range: 296-1176) per muscle. Cell proliferation is 
represented as the percentage of EdU+ nuclei in the injured muscle of target gene MO injected fish 
relative to the percentage of EdU+ nuclei in the injured muscle of control MO injected fish.  
 
2.2.7 Regeneration Assay 
Transgenic α-actin::EGFP zebrafish were used to visualize the LR muscles and measure 
regeneration by craniectomy 4 or 8 dpi (Figure 2.6 A) as described previously [9]. Briefly, calvarial 
bones of the skull and the brain were removed to allow visualization of the skull base where both 
LR muscles originate. Regeneration is represented as the length of the injured muscle compared 
to the non-injured muscle of MO injected fish relative to the length of the injured muscle compared 
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to the non-injured muscle of control MO injected fish. All experiments were performed using 5 




2.3.1 Differentially Expressed Genes During Early Muscle Regeneration 
Adult zebrafish EOMs can regenerate de novo using residual myocytes that reprogram into 
dedifferentiated myoblasts capable of proliferation. Starting with “postmitotic” myocytes, the 
entire reprogramming process takes just under 20 h, at which time myonuclear proliferation can 
be detected [9]. To characterize the reprogramming process at the transcriptional level, we chose 
to focus on two time points – 9 and 18 hpi – that occur prior to cell cycle reentry by dedifferentiated 
myoblasts. RNA was isolated from uninjured lateral rectus (LR) muscles (CON) and injured LR 
muscles at 9 (H9) and 18 (H18) hpi, followed by ribosomal RNA depletion and reverse 
transcription to prepare a cDNA library for deep sequencing utilizing an Illumina Hi-Seq platform. 
Four replicates were used for CON and five replicates were used for both H9 and H18; biological 
replicates consisted of pooled LR tissue from 15 to 20 zebrafish. Mapping against the zebrafish 
reference genome sequence revealed alignment to 31,014 unique features. 
A total of 6596 unique differentially expressed genes (DEG) were identified among CON, 
H9, and H18 samples. There were more DEGs in CON vs. H9 and CON vs. H18 comparisons 
(4717 and 4735 genes, respectively) than in H9 vs. H18 comparisons (1923 genes) (Figure 2.1 A). 
A heat map of all DEG revealed the occurrence of multiple gene subsets with distinct expression 
patterns (Figure 2.1 B). 538 DEGs were common to all three comparisons and the highest overlap 






Figure 2.1: Differential gene expression during muscle regeneration. 
A. Distribution of DEG of the three pair-wise comparisons. B. Heat map of DEG. Sample names 
are listed below the heat maps and the expression-based hierarchical clustering separating CON 
from H9 and H18 samples is shown above it. Color scale (right) indicates gene expression 
(FPKM). FPKM <5 is shown in green and indicates low transcript abundance. FPKM >5 is 
shown in red and indicates high transcript abundance. DEG are ordered according to numeric 
clusters from Figure 2.4, represented as a color bar on the left side (color code is shown in Figure 
2.4 over each cluster plot). C. Venn diagram showing overlap of DEG between CON, H9, and 
H18 sample comparisons. 
 
 
2.3.2 Functional Classification of Differentially Expressed Genes (DEG) 
Comparisons between CON, H9, and H18 samples revealed that the majority of 
significantly perturbed KEGG pathways were downregulated (Figure 2.2 A-E). About half of these 
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downregulated pathways (5 of 11) were perturbed in CON vs. H9 and CON vs. H18 comparisons 
but not in the H9 vs. H18 comparison, thus indicating a rapid and sustained change starting at 9 
hpi; see cardiac muscle contraction pathway (dre04260) for example (Figure 2.2 F). Almost all 
other downregulated pathways (4 of 11) were perturbed in each comparison indicating a gradual 
change over time; see calcium signaling pathway (dre04020) for example. On the other hand 
upregulation of the phagosome pathway (dre04145) was common to all three comparisons while 
the lysosome pathway (dre04142) was upregulated in only CON vs. H18 and H9 vs. H18 
comparisons (Figure 2.2 G). 
The magnitude of lysosome pathway (dre04142) upregulation between H9 and H18 was 
the largest of all comparisons suggesting a critical role during muscle remodeling at 18 hpi. The 
downregulation of the pathways for pyruvate metabolism (dre00620), oxidative phosphorylation 
(dre00190), citrate cycle (TCA cycle) (dre00020), 2-oxocarboxylic acid metabolism (mainly TCA 
cycle components; dre01210), glycolysis/gluconeogenesis (dre00010), and carbon metabolism 
(dre01200) suggests a reduction in the mitochondrial oxidative capacity of reprogramming cells. 
Interestingly, genes of the MAPK signaling pathway (dre04010) showed a very dynamic 
expression pattern that was only significantly downregulated between H9 and H18. This would 
indicate a change in the cellular MAPK configuration during reprogramming and expands on our 
characterization of the Erk pathway in EOM regeneration [19]. 
Comparisons between CON, H9, and H18 samples revealed that, like KEGG pathways, the 
majority of significantly perturbed GO terms were downregulated (Figure 2.3 A-I). Consequently, 
there was a general expression decrease of genes included in these GO terms (Figure 2.3 K-L). 
GO terms downregulated in all three comparisons (representing a gradual downregulation) and in 
CON vs. H18 and H9 vs. H18 (representing a late decrease in gene expression levels) were related 
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to similar categories including muscle development, differentiation and function [muscle fiber 
development (GO:0048747), muscle cell differentiation (GO:0042692), z disc (GO:0030018), and 
striated muscle contraction (GO:0006941)]; nucleic acid metabolism [nucleoside metabolic 
process (GO:0009116), pyridine nucleotide metabolic process (GO:0019362), and purine 
nucleotide metabolic process (GO:0006163)]; energy metabolism [oxidation-reduction process 
(GO:0055114), tricarboxylic acid cycle (GO:0006099), proton-transporting ATP synthase 
complex (GO:0045259), mitochondrial inner membrane (GO:0005743), and carbohydrate 
catabolic process (GO:0016052)]; and calcium related processes [cellular calcium ion homeostasis 
(GO:0006874), calcium ion binding (GO:0005509), and calcium ion transport (GO:0006816)]. 
Interestingly, genes of GO terms related to catabolic functions were mainly upregulated at the 
expression level (Figure 2.3 J-L). Specifically, GO term upregulation was only observed in CON 
vs. H18 and H9 vs. H18 comparisons and consisted primarily of catabolic functions such as 
cysteine-type peptidase activity (GO:0008234), lysosome (GO:0005764), and cellular protein 
catabolic process (GO:0044257). The internal consistency between the KEGG pathways and GO 
terms obtained (e.g., cardiac muscle contraction and striated muscle contraction, calcium signaling 
pathway, cellular calcium ion homeostasis, and lysosome in both KEGG and GO analyses) 





Figure 2.2: KEGG pathway classification of differentially expressed genes. 
Volcano plots of KEGG pathways in CON vs H9 (A), CON vs H18 (B), and H9 vs. H18 (C) 
comparisons. Gene set expression change (x-axis) of DEG within a KEGG pathway is a 
normalized enrichment score based on comparisons between different time points and relative to 
the entire DEG gene set. Significantly downregulated pathways are shown in green and 
significantly upregulated pathways are shown in red. D Distribution of significantly perturbed 
KEGG pathways in the three pair-wise comparisons. Significantly downregulated terms are 
shown in green. Significantly upregulated terms are shown in red. Cutoff for significance was q 
< 0.1 according to default values and parameters of the R package “gage” v2.22.0. E Venn 
diagram showing overlap of perturbed KEGG terms between CON, H9, and H18 sample 
comparisons. Cutoff for significance was q < 0.1 according to default values and parameters of 
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the R package “gage” v2.22.0. Fold change (H18/CON) of the DEG of the dre04260 Cardiac 





Figure 2.3: GO enrichment analysis of differentially expressed genes. 
Volcano plots of significantly perturbed GO terms of biological process (BP; A, B, C), cellular 
component (CC; D, E, F) and molecular function (MF; G, H, I) in CON vs H9 (A, D, G), CON 
vs H18 (B, E, H), and H9 vs. H18 (C, F, I) comparisons. Gene set expression change (x-axis) of 
DEG mapped to GO term is a normalized enrichment score based on comparisons between 
different time points and relative to the entire DEG gene set. Significantly downregulated terms 
are shown in green and significantly upregulated terms are shown in red. Cutoff for significance 
was q < 0.1 according to default values and parameters of the R package “gage” v2.22.0. 




2.3.3 Gene Expression Profiles 
K-means clustering of DEG identified 18 clusters that were further arranged by expression 
patterns into 4 major profiles composed of multiple gene clusters and 6 minor profiles composed 
of a single gene cluster (Figure 2.4). The first major profile, “A: Progressive Downregulation”, 
was composed of 994 genes (clusters 1, 3, and 7, Figure 2.4 A) and showed progressive and 
significant downregulation at 9 hpi and 18 hpi. This profile groups together genes such as 
myogenic factor 6 (myf6); collagen, type XV, alpha 1a (col15a1a); obscurin, cytoskeletal 
calmodulin and titin-interacting RhoGEF a (obscna); popeye domain containing 2 (popdc2); 
acetylcholinesterase (ache); matrix metallopeptidase 23bb (mmp23bb); serine peptidase inhibitor, 
Kunitz type 1 b (spint1b); Indian hedgehog homolog a (ihha); lefty2 (lft2); titin, tandem duplicate 
1 (ttnb); periostin, osteoblast specific factor b (postnb); sarcoglycan, delta, dystrophinassociated 
glycoprotein (sgcd); SIX homeobox 1b (six1b); SET and MYND domain containing 1a (smyda1); 
and SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, 
member 1 (smarca1). 
The second major profile, “B: Persistent Downregulation”, was composed of 1723 genes 
(clusters 4, 10, and 11, Figure 2.4 B) and showed downregulation at 9 hpi that was maintained at 
similar levels through 18 hpi. Representative genes of this profile include laminin alpha 2 (lama2); 
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myogenin (myog); collagen, type VI, alpha 1 (col6a1); caveolae associated protein 4a (murca); 
myogenic differentiation 1 (myod1); myocyte enhancer factor 2d (mef2d); insulin-like growth 
factor 1a receptor (igf1ra); sarcoglycan beta, dystrophin-associated glycoprotein (sgcb); myosin, 
heavy polypeptide 2, fast muscle specific (myhz2); laminin beta 2, laminin S (lamb2); dystropin 
(dmd); tropomodulin 4, muscle (tmod4); tropomodulin 1 (tmod1); NDRG family member 4 
(ndrg4); insulin-like growth factor binding protein 3 (igfbp3); LIM domain binding 3a (ldb3a); 
and RNA binding motif protein 24b (rbm24b). 
The third major profile, “C: Persistent Upregulation”, was composed of 2172 genes 
(clusters 2, 5, 13, and 14, Figure 2.4 C) that were upregulated at 9 hpi and maintained their 
expression levels through 18 hpi. Representative examples from this profile include DNA 
(cytosine-5-)-methyltransferase 3 alpha a (dnmt3aa); SWI/SNF related, matrix associated, actin 
dependent regulator of chromatin, subfamily a, member 5 (smarca5); ATPase, H+ transporting, 
lysosomal, V1 subunit E1b (atp6v1e1b); RNA binding protein, fox-1 homolog (C. elegans) 2 
(rbfox2); selenoprotein N, 1 (sepn1); protein arginine methyltransferase 1 (prmt1); metastasis 
associated 1 family, member 2 (mta2); histone deacetylase 1 (hdac1); proteasome 26S subunit, 
non-ATPase 11b (psmd11b); ubiquitin-like modifier activating enzyme 1 (uba1); mesoderm 
posterior aa (mespaa); cardiotrophin-like cytokine factor 1 (clcf1); minichromosome maintenance 
10 replication initiation factor (mcm10); integrin, alpha 6a (itga6a); myelocytomatosis oncogene 
homolog (myc h); SWI/SNF related, matrix associated, actin dependent regulator of chromatin, 
subfamily a, member 4a (smarca4a); matrix metallopeptidase 9 (mmp9); and regulator of 
chromosome condensation 2 (rcc2). 
The fourth major profile, “D: Delayed Downregulation”, was composed of 477 genes 
(clusters 6 and 17, Figure 2.4 D) that were unchanged through 9 hpi but were significantly 
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downregulated at 18 hpi. The following are representative examples of the genes included in this 
profile: autophagy/beclin-1 regulator 1a (ambra1); unc- 45 myosin chaperone B (unc45b); 
cadherin 5 (cdh5); insulin-like growth factor 1b receptor (igf1rb); actin, alpha 2, smooth muscle, 
aorta (acta2); methionine adenosyltransferase II, alpha a (mat2aa); and troponin I type 1a, skeletal, 
slow (tnn1ai). 
The remaining single cluster profiles represented more dynamic “switch-like” expression 
patterns (Figure 2.4 E-J) and, as such, were of particular interest. Of those, “E: Transient 
Activation” (cluster 8, Figure 2.4 E) contained 129 genes (such as mesoderm posterior bb, mespbb; 
nanor, nnr; hemoglobin beta embryonic-2, hbbe2; tetraspanin 34, tspan34; and claudin 1, cldn1) 
that were only expressed at 9 hpi, while “F: Transient Upregulation” (cluster 9, Figure 2.4 F) 
contained 648 genes (e.g., enhancer of zeste 2 polycomb repressive complex 2 subunit, ezh2; 
coactivator-associated arginine methyltransferase 1, carm1; SWI/SNF related, matrix associated, 
actin dependent regulator of chromatin, subfamily d, member 1, smarcd1; protein arginine 
methyltransferase 5 and 7, prmt5 and prmt7; MYC proto-oncogene, bHLH transcription factor b, 
mycb) that were present in uninjured muscles (CON), peaked at 9 hpi, and returned to control 
levels at 18 hpi. Such rapid yet transient changes in expression suggest involvement of these gene 
clusters in the initiation of cell reprogramming. Profile “G: Late Upregulation” (cluster 12, Figure 
2.4 G) contained genes upregulated at 18 hpi such as fibronectin 1a (fn1a); DNA (cytosine-5-)-
methyltransferase 1 (dnmt1); midkine a (mdka); DNA primase subunit 2 (prim2); or DNA 
topoisomerase II alpha (top2a). Profile “H: Transient Repression” (cluster 15, Figure 2.4 H) 
contained 42 genes present in uninjured (CON) muscles and at 18 hpi but not expressed at 9 hpi. 
Representative examples are histone H2A, sperm-like; claudin d (cldnd); period circadian clock 
1a (per1a); and glutathione peroxidase 7 (gpx7). Profile “I: Persistent Repression” (cluster 16, 
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Figure 2.4 I) contained 85 genes that were only expressed in uninjured (CON) muscles (e.g., 
chymotrypsinogen B1, ctrb1; cysteine three histidine 1, cth1; cyclin A1, ccna1) while the 67 genes 
of profile “J: Late Activation” (cluster 18, Figure 2.4 J) displayed the opposite trend and were only 
expressed at 18 hpi (although this was the cluster with the highest content of non-coding 
transcripts, see below, some representative coding genes are aspartic peptidase, retroviral-like 1, 
asprv1; chemokine (C-C motif) ligand 27b, ccl27b; and heparan sulfate 6-O-sulfotransferase 3a, 
hs6st3a). 
Panther GO term analysis of the four major profiles revealed GO terms consistent with the 
previous analysis conferring reliability to the results (Figure 2.4 K, L). Analysis of “A: Progressive 
Downregulation” genes showed enrichment in categories of muscle organ development 
(GO:0007517), small molecule metabolic process (GO:0044281), and single-organism cellular 
process (GO:0044763) (Figure 2.4 K). Panther analysis identified 15 different enriched categories 
in “B: Persistent Downregulation” (Figure 2.4 K), including skeletal muscle organ development 
(GO:0060538), myofibril assembly (GO:0030239), heart development (GO:0007507), and organ 
morphogenesis (GO:0009887). “C: Persistent Upregulation” had 31 overrepresented categories 
(Figure 2.4 L), the highest number of any Panther analysis. Several RNA processing [such as 
mRNA splicing, via spliceosome (GO:0000398), RNA secondary structure unwinding 
(GO:0010501), RNA export from nucleus (GO:0006405), mRNA transport (GO:0051028)] and 
protein translation [protein folding (GO:0006457), translational initiation (GO:0006413), 
ribosomal large subunit biogenesis (GO:0042273), cytoplasmic translation (GO:0002181)] or 
modification [protein folding (GO:0006457) and protein N-linked glycosylation (GO:0006487)] 
categories were identified. At the same time, protein degradation [ubiquitin-dependent protein 
catabolic process (GO:0006511) and lysosome organization (GO:0007040)] and fin regeneration 
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(GO:0031101) categories were also enriched. Enriched categories in “D: Delayed 
Downregulation” (Figure 2.4 K) were related to developmental and differentiation processes such 
as cell differentiation (GO:0030154) or tissue development (GO:0009888). 
Interestingly, the Panther GO analysis of single cluster profiles revealed relevant terms not 
noted in other profiles or the GAGE analysis. Enriched terms in “F: Transient Upregulation” were 
related to the categories of gene transcription and ribosome formation and included: regulation of 
gene expression, epigenetic (GO:0040029), transcription, DNAtemplated (GO:0006351), and 
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) 
(GO:0000462). Enriched categories in “G: Late Upregulation” were related to DNA replication 
and repair [DNA replication initiation (GO:0006270), mismatch repair (GO:0006298), and mitotic 
chromosome condensation (GO:0007076)]. Profiles “E: Transient Activation”, “H: Transient 
Repression”, “I: Persistent Repression”, and “J: Late Activation” did not have enriched GO terms 
or categories because of the low percentage of GO annotations for genes in these clusters (Table 
2.2). Interestingly, the gene clusters with lowest percentage of GO annotated terms had both a 
higher percentage of lncRNAs (Table 2.3), which remain to be functionally annotated, and the 
most dynamic “switch-like” expression patterns (Figure 2.4). 
 
 















            
A (1/3/7) 994 671 67.51 
B (4/10/11) 1723 1296 75.22 
C (2/5/13/14) 2172 1682 77.44 
D (6/17) 477 309 64.78 
E (8) 129 23 17.83 
F (9) 648 476 73.46 
G (12) 259 32 12.36 
H (15) 42 14 33.33 
I (16) 85 24 28.24 









Figure 2.4:  Expression profiles of gene clusters. 
K-means method was used to divide DEG into 18 clusters that were grouped, according to their 
expression profiles, into 4 major profiles (A-D) and 6 profiles composed of single gene clusters 
(E-J). A The first major profile, “Progressive Downregulation” (clusters 1, 3, and 7) showed 
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progressive and significant downregulation at 9 hpi and 18 hpi. B The second major profile, 
“Persistent Downregulation” (clusters 4, 10, and 11) grouped downregulated genes at 9 hpi that 
maintained similar expression levels through 18 hpi. C Genes of the third major profile, 
“Persistent Upregulation” (clusters 2, 5, 13, and 14), were upregulated at 9 hpi and maintained 
through 18 hpi. D The fourth major profile, “Delayed Downregulation” (clusters 6 and 17) 
included genes whose expression was significantly downregulated only at 18 hpi. The remaining 
single cluster profiles (E-J) presented more dynamic time changes. E “Transient Activation” 
(cluster 8) contains genes that were only expressed at 9 hpi. F “Transient Upregulation” (cluster 
9) represents genes present in control that were significantly upregulated at 9 hpi and returned to 
control levels at 18 hpi. G “Late Upregulation” (cluster 12) contains genes whose expression was 
upregulated at 18 hpi. H “Transient Repression” (cluster 15) is composed of genes expressed in 
control muscles and at 18 hpi but not expressed at 9 hpi. I “Persistent Repression” (cluster 16) 
contains genes that were only expressed in control muscles. J “Late Activation” (cluster 18) 
displayed the opposite trend with genes only expressed at 18 hpi. The color behind the cluster 
number is related to the color bar in Figure 2.1 B. (K-L) GO enrichment analysis of the major 
gene expression profiles A-D. (K) Significantly overrepresented GO categories in profiles with 
genes downregulated over time (profiles A, B and D). (L) Significantly overrepresented GO 
categories in profile C which had persistently upregulated genes. Categories with P < 0.05 were 
considered as significantly overrepresented  
 
 
2.3.4 Expression Timing Correlates with Temporal Roles During Muscle Regeneration 
As anticipated, a large subset of epigenetic regulators and transcription factors were 
induced early in the reprogramming process (profile “F: Transient Upregulation”; Figure 2.4 F). 
In fact, the GO term “regulation of gene expression, epigenetic” (GO:0040029) was significantly 
enriched in profile F. All this suggested that at least a subset of these factors might be 
mechanistically involved in allowing post-mitotic myocytes to dedifferentiate into proliferative 
myoblasts and we thus decided to focus on transcription factors and epigenetic regulators. We 
further hypothesized that early-activated genes would play a particularly important role in the 
reprogramming and dedifferentiation of injured myocytes, and tested the hypothesis using gene 
knockdown experiments using antisense morpholino oligonucleotide (MO), a technique widely 
used to perform tissue-specific knockdown experiments in adult zebrafish [31–33] and other model 
organisms such as adult axolotls [39], xenopus larvae [40] or chick [41] and mouse [42] embryos. 
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Briefly, lissamine-tagged MOs are injected and then electroporated into the LR muscle 3 h prior 
to myectomy injury (Figures 2.5 A and 2.6 A). LR-specific MO uptake is detected via lissamine 
fluorescence within muscle fibers, persisting through 8 dpi, and without affecting the adjoining 
EOM (Figure 2.6 B). Proliferation at 48 hpi is assayed via EdU uptake as a surrogate for myocyte 
reprogramming, since proliferation of dedifferentiated myoblasts represents the final step of the 
reprogramming process (Figure 2.5 E). Additionally, we physically measure the length of the 
regenerating LR muscle in order to assess anatomic regeneration (Figure 2.6 B). 
Because of their rapid induction (Figure 2.5 B), gene induction in a “switch-like” fashion 
(i.e., expression profile “F: Transient Upregulation”), and known roles as epigenetic regulators of 
cell identity [43], we assessed the role of Polycomb group factors in myocyte reprogramming. 
Knockdown of the Polycomb Repressive Complex 2 (PRC2) factors Ezh2 and Suz12a revealed a 
significant reduction in the number of proliferating dedifferentiated myoblasts during what is 
normally peak proliferation [9], between 44 and 48 hpi (Figure 2.5 E), supporting a key role in the 
reprogramming process. Furthermore, physical measurement of LR muscle length following 
Polycomb group factor knockdown revealed a significant delay in muscle regeneration (Figure 2.6 
C) that was consistent with the inhibition of reprogramming and subsequent proliferation. These 
findings reveal a key role for PRC2 factors in regulating myocyte reprogramming.  
Next, we hypothesized that since myocyte dedifferentiation to myoblasts represents the 
first step of the muscleto-mesenchymal transition (MMT) observed during EOM regeneration [9], 
later activated (i.e., 18 hpi) genes would not be related to myocyte reprogramming and cell cycle 
reentry but rather play important roles in muscle tissue anatomic regeneration. Among genes in 
the single cluster profile “G: Late Upregulation”, fn1a, encoding fibronectin –an extracellular 
matrix (ECM) glycoprotein whose expression is activated during mesenchymal transitions and 
58 
 
promotes cell migration [44] – was notable due to its magnitude of induction between 9 and 18 hpi 
(Figure 2.5 C). As hypothesized, knockdown of Fn1a had no effect on cell proliferation (Figure 
2.5 E). However, it resulted in a large reduction in anatomic LR muscle tissue regeneration (Figure 
2.6 B and C). This is consistent with the hypothesis that genes activated later in the response were: 
(1) not significant for the cellular reprogramming process, and (2) more important for later events 






Figure 2.5: Proliferation following knockdown of select differentially expressed genes. 
A. LR regeneration involves a proliferative burst that generates enough cells to replace lost 
tissue. EdU assays were performed according to the schematic. B. Gene expression (FPKM) of 
epigenetics selected genes, ezh2 and suz12a. C. Fibronectin 1a gene expression (FPKM). D. 
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Confocal microscopy of cell proliferation in the regenerating muscle. Inset shows higher 
resolution detail of the box in the panel. DAPI staining (blue) shows the total number of nuclei in 
the muscle (left) and EdU staining (red) shows proliferating nuclei (middle). Merged panel 
(right). E. Quantification of cell proliferation in injured LR at 48 hpi. Values are averages ± SEM 
(n ≥ 5) in control MO or target gene MO injected fish. Different letters (a, b, ab) in (b) and (c) 




Figure 2.6: Regeneration following knockdown of select differentially expressed genes. 
A. LR regeneration assays were performed according to the schematic. B. Craniectomy was 
performed to visualize EGFP-labeled muscle at 8 dpi. Brain was removed to allow visualization 
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of the skull base (*) Microinjected MOs are detected throughout the entire regenerating muscle, 
including the distal ends (white arrow). Control MO (left) and fn1a MO (right) injected fish are 
pictured. C. Quantification of LR regeneration at 8 dpi, all MOs targeting specific mRNA 
decreased muscle regeneration at 8 dpi compared to control MO injected fish. Values are 
averages ± SEM (n = 5–7) in control MO or target gene MO injected fish. *P < 0.05; **P < 0.01; 
*** P < 0.001; Student’s t-test. The residual muscle left following myectomy surgery (46.77 ± 




Differentiated cells are marked by an epigenetic program that determines which genes are 
to be expressed or repressed in a genome-wide fashion [45–47]. The myocyte program involves 
expression of genes encoding sarcomeric proteins and repression of cell cycle genes and those 
associated with different, non-muscle tissue types (e.g., liver). Reprogramming a differentiated 
cell into a different identity, whether or not of similar cell lineage, would involve reprogramming 
every aspect of that cell’s biology – its transcriptome, metabolome, and proteome. Myocytes are 
among the most specialized of cells and are considered “post-mitotic.” Yet, in zebrafish EOMs, 
catastrophic muscle injury triggers rapid myocyte reprogramming (within 20 hpi) resulting in a 
large population of proliferating dedifferentiated myoblasts that repopulate and de novo regenerate 
the absent muscle [9,48,49]. This surprising discovery has provided a unique opportunity to study 
limited cellular reprogramming that maintains lineage restriction yet is capable of regenerating 
skeletal muscle de novo. 
In order to understand the mechanism of myocyte reprogramming, we utilized a deep 
sequencing approach to characterize the early transcriptional changes that occur as post-mitotic 
myocytes reprogram into dedifferentiated myoblasts capable of proliferation. Two parallel 
strategies, GAGE analysis (KEGG pathways and GO terms) or K-means clustering followed by 
Panther GO term enrichment analysis, were used to functionally annotate all 6596 DEGsadd. 
Broadly speaking, both strategies gave similar results, conferring reliability to our analyses. Our 
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results reveal that myocyte dedifferentiation is marked by downregulation of muscle-specific 
programs, such as the sarcomeric apparatus and calcium homeostasis. Additionally, both parallel 
GO term analyses (GAGE and Panther enrichment analysis) revealed a downregulation of terms 
more broadly related to cellular differentiation and tissue or organ morphogenesis. The 
downregulation of pyruvate metabolism, oxidative phosphorylation, TCA cycle pathways, 
pyruvate metabolic processes, proton-transporting ATP synthase complexes, and mitochondrial 
ATP synthesis reflects a decrease in the need for mitochondrial oxidative capacity in 
dedifferentiating cells. This is similar to the processes of somatic and oncogenic cellular 
reprogramming to a pluripotent state in which reprogrammed cells undergo metabolic “rewiring” 
that reduces both mitochondrial content and oxidative phosphorylation capacity [50–54]. 
Interestingly, autophagy activation reduces mitochondrial content early in reprogramming [55] 
and, although our analysis did not find any significant autophagy-specific KEGG pathways or GO 
terms, we have previously shown that autophagy plays a key role in zebrafish muscle regeneration 
[48]. The absence of significant autophagy-specific KEGG pathways or GO terms is not surprising 
since, in this model, autophagy is regulated mainly at the protein level [48]. Notably, we found a 
consistent upregulation of terms related to lysosomal protein degradation – the last step of the 
autophagy process – including the lysosome KEGG pathway and the GO terms cysteine-type 
peptidase activity and lysosome organization. 
In addition to the already discussed pathways and terms, enrichment analysis of unbiased 
k-means clustering expression profiles revealed several interesting GO terms. Enriched GO terms 
within “G: Late Upregulation” genes included DNA replication, chromosome condensation, and 
DNA biosynthesis, all of which are consistent with reprogramming cells preparing to reenter the 
cell cycle. The timing of upregulation within this profile (i.e., 18 hpi) correlates well with our 
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published results showing that cell proliferation (EdU incorporation into DNA) begins by 20–24 
hpi [9]. A recent bioinformatic analysis of zebrafish heart regeneration identified similar changes 
in energy metabolism, amino-acid biosynthesis and DNA replication linked to the initial 
proliferative response [56], indicating shared molecular mechanisms between these regenerative 
processes. The reacquisition of proliferative potential, importantly, represents the most 
fundamental aspect of the reprogramming process. Supporting this finding, pharmacological 
inhibition of the cell cycle with either bortozemid or 5-fluorouracil blocks the muscle-
tomesenchymal transition that drives EOM regeneration [8]. 
Terms related to mRNA processing, mRNA transport, and protein translation and 
modification were enriched in “C: Persistent Upregulation” genes (Figure 2.4 C) which were 
upregulated at 9 and 18 hpi. Additionally, genes only upregulated at 9 hpi (“F: Transient 
Upregulation”, Figure 2.4 F) were related to transcription, rRNA maturation, tRNA processing, 
and epigenetic regulation of transcription. These findings indicate that the cells are preparing to 
synthesize a new set of proteins that, in conjunction with broad protein degradation, would allow 
the cell to perform the drastic cellular proteome changes that reprogramming requires [57]. 
Interestingly, the GO term “fin regeneration,” enriched in “C: Persistent Upregulation” genes 
(Figure 2.4 C), was upregulated at 9 and 18 hpi, and included hdac1 (histone deacetylase 1) and 
smarca4a (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily 
a, member 4a). These genes, along with GO terms related to epigenetic regulation of transcription, 
confirm the importance of chromatin-dependent gene expression changes during the 
reprogramming process. 
Based upon functional annotations, we hypothesized that important initiators of 
dedifferentiation would belong to expression profile “F: Transient Upregulation”, which peak at 9 
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hpi and return to control levels at 18 hpi, and that morpholino knockdown of these genes would 
both interfere with cell cycle reentry and impair the anatomic EOM regeneration. Profile “F: 
Transient Upregulation” candidates were ezh2, encoder of Polycomb group protein that broadly 
regulate epigenetic states [43]. Although delayed anatomic regeneration following Ezh2 
knockdown supported the regulatory importance of profile “F: Transient Upregulation” genes, the 
true test remained the ability to affect cell cycle reentry within dedifferentiated myoblasts. 
Knockdowns of Ezh2 reduced the proportion of proliferating myoblasts, thus bolstering the 
importance of these and other dynamically expressed profile “F: Transient Upregulation” genes as 
“switch”-like regulators of EOM dedifferentiation leading to regeneration. In line with our results, 
mammalian EZH2 promotes proliferation by modifying chromatin conformation in models of 
pancreas [58], liver [59], and dental pulp regeneration [60]. Importantly, knockdown of the Ezh2 
Polycomb partner Suz12a replicated Ezh2 knockdown results, thus confirming the relevance of 
epigenetic regulation in myocyte reprogramming. In addition to the discussed role in promoting 
cell cycle reentry, PCR2 factors may play an additional transient role repressing muscle identity 
since PRC2 factors maintain the chromatin state of muscle genes in a repressive conformation and 
must be degraded to allow myogenic differentiation [61]. 
We further hypothesized that genes with later activation (18 hpi) would affect post-
reprogramming processes. Profile “G: Late Upregulation” included the ECM factor fn1a 
(fibronectin) whose knockdown, unlike those in profile “F: Transient Upregulation”, resulted in a 
robust defect in anatomic regeneration with no effect on proliferation. Our results are supported 
by reports showing that fn1a was required for zebrafish heart regeneration but not for 
cardiomyocyte dedifferentiation and subsequent proliferation [62]. It was also found to be 
upregulated in microarray analyses of zebrafish heart [56,63] and fin [64] regeneration, validating 
65 
 
this transcriptomic assessment and suggesting the existence of common features among tissue 
regeneration models. Interestingly, fn1a was also identified in a correlation of fin regeneration 
genes with melanoma markers [65], highlighting again the similarities between regeneration and 
cancer. The data supports the hypothesis that while the regeneration process may take days, the 
transcriptional template for the entire process is determined at the outset of the regeneration 
process: early activated genes regulate initial reprogramming events, while late response genes 
regulate tissue growth. These findings reveal the temporal relationship that correlates 




We describe a transcriptome analysis of an in vivo dedifferentiation process during which 
myocytes reprogram to become myoblasts that regain the capacity to proliferate. Our analysis 
reveals a complex and coordinated process (Figure 2.7) that begins with downregulated expression 
of genes that confer muscle identity, significant changes in metabolic programs, coordinated 
activation of protein degradation that clears the sarcomere and other muscle-specific protein 
complexes, and the synthesis of new proteins that reshape the proteomic cellular profile. 
Simultaneously, activation of programs related to DNA replication, repair, and chromosome 
condensation, as well as of genes required for the G-to-S transition, ultimately leads to cell cycle 
reentry by reprogrammed myocytes and the formation of dedifferentiated myoblasts. The early 
and temporally regulated activation of genes related to epigenetic regulation of transcription likely 
drives the broad programmatic genomic changes required for myocyte dedifferentiation. We 
propose a mechanistic overview of the temporal orchestration of pathways involved in cellular 
reprogramming. We also assess the importance of early-activated chromatin remodeling factors 
66 
 
(Ezh2 and Suz12a) during the dedifferentiation and cell cycle reentry of “post-mitotic” myocytes. 
On the other hand, late activated genes, like fn1a (encoding an extracellular matrix interacting 
protein), would regulate the anatomic growth of regenerating muscle tissue following cellular 
reprogramming. 
Understanding the molecular mechanism of cellular reprogramming that leads to lineage-
restricted proliferating progenitor cells carries particular importance to the field of de novo tissue 
regeneration. Furthermore, the similarities between tissue regeneration and cancer (for example, 
cell reprogramming and dedifferentiation, proliferation and migration) may suggest a similar 
relationship between genes that control “stemness” and those that regulate metastasis. Future 





Figure 2.7: Proposed coordinated process of myocyte reprogramming 
Reprogramming “post-mitotic” myocytes into dedifferentiated myoblasts would require a 
complex, temporally sensitive, orchestration of genes and pathways involved in the regulation of 
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Chapter 3: Role of twist3 in Craniofacial Muscle Regeneration3 
 
3.1 Introduction 
Skeletal muscle injuries and degenerative conditions are common, debilitating, and 
significant causes of morbidity and mortality worldwide [1, 2]. Despite the pervasiveness of injury, 
mammalian muscle repair is limited by the extent of tissue damage and restricted by the amount 
of resident stem cells (i.e. satellite cells) available for tissue replacement [3]. This differs from 
non-mammalian vertebrates such as zebrafish which robustly regenerate both skeletal and cardiac 
muscle as well as other tissues including retina, spinal cord, liver, and fin [4-8]. Such extensive 
repair, or rather whole tissue regeneration, relies less on the activation of resident stem cells and 
more on cell reprogramming and dedifferentiation [9, 10]. Understanding the mechanisms 
underlying adult de novo muscle regeneration in model vertebrates thus represents a topic with 
widespread clinical therapeutic implications [2, 11]. Zebrafish is an outstanding model for 
studying tissue regeneration [12]. Our lab has developed a novel zebrafish-based system to study 
regeneration of extraocular muscles (EOMs) - a form of skeletal muscle whose regeneration is 
driven by myocyte dedifferentiation with no significant contribution from satellite cells [10].  
The twist family of basic helix-loop-helix (bHLH) transcription factors (TFs) represent an 
evolutionarily conserved family of proteins that regulate stem cells during both embryonic 
development [13-15] and adult progenitor cell maintenance [16]. Twist orthologs are also known 
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regulators of muscle formation and regeneration in Drosophila [17, 18], muscle stem cells during 
mouse development [19], and skeletal muscle repair in adult mice [20, 21]. Zebrafish have 4 twist 
homologs - twist1a, twist1b, twist2, and twist3 - which are orthologs of mammalian twist1 and 
twist2 [22] and are necessary for proper craniofacial development [23]. The prevailing belief that 
regeneration is a recapitulation of embryonic development led us to hypothesize that twist TFs are 
involved in adult extraocular muscle (EOM) regeneration. We therefore sought to identify which 
zebrafish twist homologs participate in the regeneration process and at what timepoint.  
Utilizing our established regeneration model, we report that twist3 is the sole twist TF 
required for EOM regeneration in adult zebrafish. Knockdown of twist3 significantly impairs 
muscle regeneration by decreasing myofiber dedifferentiation and cell proliferation post-injury.  
These findings suggest that twist3 plays an early role during the myocyte dedifferentiation process 
that precedes cell cycle re-entry.  Additionally, knockdown of other zebrafish twist homologs (i.e. 
twist1a, twist1b, and twist2) did not affect regeneration parameters, thereby suggesting 




3.2 Materials and Methods 
3.2.1 Zebrafish (Danio rerio) Rearing and Surgeries 
All animal work was performed in compliance with the ARVO Statement for the Use of 
Animals in Ophthalmic and Vision Research and approved by the University of Michigan 
Committee on the Use and Care of Animals, protocol 06034. Sexually mature adult (4–18 month-
old) zebrafish were spawned in our fish facility and raised per standard protocol [24] at 28 °C with 
a 14-h light/10-h dark alternating cycle.  
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Adult zebrafish were anesthetized using 0.05% tricaine methanosulfate (Tricaine-S; 
Western Chemical, Ferndale, WA) with 0.05% sodium bicarbonate buffer and about 50% of the 
lateral rectus (LR) muscle was surgically excised, i.e. myectomy. The length of the regenerating 
muscle was quantified by craniectomy as described previously [25]. Regeneration is represented 
as the relative size of the injured LR muscle normalized to the length of the uninjured LR muscle 
(representing 100%). All experiments were performed using 5 fish per experimental group and/or 
time point, unless stated otherwise in the text and/or figure legend. 
 
3.2.2 Twist TFs Customized Antibody 
Polyclonal rabbit antibodies to twist proteins (twist1a, twist1b, twist2, and twist3) were 
custom produced by Hitag Biotechnology, Lda, Cantanhede Portugal. Briefly, codon optimized 
6x-His tagged proteins were expressed in bacteria, the protein was purified using multiple steps 
and the His-tag removed with tobacco etch virus (TEV) protease. Rabbits were immunized with 
the purified proteins and the resulting sera purified by Protein A affinity chromatography. Twist 3 
antibodies were further affinity purified using His-tagged zebrafish twist3 over-expressed protein 
(expressed in HEK293 cells) and affinity purified using cobalt-IMAC chromatography. The 
purified tagged twist 3 protein was coupled to a MicroLink™ Protein Coupling Kit column (Pierce, 
Rockford, IL) and the antibodies purified according to the manufacturer’s instructions. Antibodies 
were validated for Western blot specificity utilizing mammalian over-expression plasmids 
transiently transfected into HEK293 cells with Lipofectamine 2000 (Invitrogen, Carlsbad CA). 
 
3.2.3 Protein Extraction, Immunoprecipitation, and Western Blots 
For embryo protein extraction, dechorionated and deyolked zebrafish embryos were pooled 
and homogenized in RIPA lysis buffer (Cell Signaling Technology, Danvers, MA) in a ratio of 
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100 µL RIPA/30 embryos. For adult LR muscle protein extraction, transgenic Tg(α-actin::EGFP) 
fish were used to visualize the muscles. Muscle tissue were collected as previously described [26]. 
Injured or uninjured LR were pooled in denaturing buffer (1% SDA, 5mM EDTA, 10mM beta-
mercaptoethanol, Protease inhibitors, 15 U/ml DNase1) in a ratio of 30 muscle/100 µL buffer and 
homogenized by passing lysis through a 27-gauge needle attached to a 1 mL syringe. Heat samples 
to 95 °C for 5 min to denature and centrifuge to collect supernatant. Protein concentrations were 
determined by BCA assay (Thermo Scientific, 23227).  
Same amount of protein (~100 uL) were diluted by non-denaturing buffer (20 mM Tris 
HCl, 137 mM NaCl, 10% glyceral, 1% NP-40, 2mM EDTA) to make a total volume of 1mL and 
proceed with the immunoprecipitation. 
Protein samples were incubated with customized twist antibodies 1:100 at 4°C with 
continuous mixing overnight. The following day, 200 µL washed PureProteome™ Protein A 
Magnetic Beads (Cat. No. LSKMAGA02, Lot 2674904A, Germany) were added per 1 mL of 
sample, and this was allowed to incubate for 45-60 minutes at 4°C with continuous mixing. The 
supernatant was removed, and the beads were washed 3x5min with 0.1% PBS-Tween20. After the 
last wash, the buffer was removed, and Laemmli Sample buffer was added proportional to number 
of muscles collected. This was boiled at 90°C for 10 minutes before removing the solution for use 
in Western blots. 
Anti-Tubg1 (1:1000, Sigma, T5326), anti-beta actin (1:30,000, Santa Cruz, sc-47778 
HRP), anti-p-histone H3 (1:1000, Cell Signaling Technology, 9701), and customized twist TFs 




3.2.4 Drug Treatments 
SU5402 (Selleckchem, Houston, TX) was dissolved in DMSO as a 17 mM stock and added 
to fish water at a final concentration of 17 μM as described [27], tanks were kept in the dark. Up 
to 5 fish were treated in 250 mL of water, tanks were maintained at 28.5°C, and drug solutions 
were replaced every 24 h. Drug treatments were performed 24 h before surgery and no significant 
mortality was noted. 
 
3.2.5 Morpholino Oligonucleotide Injection and Electroporation 
Microinjection of morpholino oligonucleotides (MOs; Gene-Tools, LLC, Philomath, OR) 
- a widely used technique to perform knockdown experiments in zebrafish [29–31] - was used. To 
knockdown genes in adult EOMs, lissamine-tagged MOs were directly microinjected into the right 
LR muscle of Tg(α-actin::EGFP) adult fish, followed by square-wave electroporation (6 to 10 
pulses at 48 V/cm, BTX ECM830 electroporator; Harvard Apparatus, Holliston, MA). 
Microinjections were performed 4 h prior to LR injury, and MO uptake was confirmed via 
lissamine fluorescence prior to myectomy. No mortality was detected during the experimental 
process. MO sequences are listed in Table 1; a standard control MO targeting a mutated splice site 
of human β-globin mRNA was injected for each experiment as negative control.  
 
 






3.2.6 EdU Incorporation Assay 
Cellular proliferation was assessed by intra-peritoneal (IP) injections of 5-ethynyl-2’-
deoxyuridine (EdU) and standard detection methods [10]. Fish were anesthetized and injected with 
EdU (20 µL, 10 mM EdU in PBS) at 20 hpi or 44 hpi and sacrificed 4 h later (24 hpi or 48 hpi). 
For each experiment, 3 fish per group were analyzed. The injured muscle of each fish was analyzed 
with both EdU-positive and total (DAPI-positive) nuclei counted from 3 nonconsecutive sections 
per muscle. Representative sections had approximately 1800 total nuclei (range 812–3016) per 
muscle. Cell proliferation is represented as the percentage of EdU-positive nuclei in the injured 
muscle. 
 
3.2.7 Specimen Processing 
Zebrafish heads were excised and decalcified using Magic-EDTA (10% EDTA, saturated 
ammonium sulfate in PBS, Ph7.4) for 3 days. Decalcified tissues were fixed in 4% 
paraformaldehyde (PFA) overnight at 4°C. Decalcified and fixed tissues were cryoprotecteded 
with 20% sucrose in PBS, embedded in OCT (Fisher Scientific), frozen, and evaluated 
microscopically using coronal frozen sections (12 μm) as described previously [10]. 
 
Name Sequence 









Comparisons between 2 groups were analyzed by Student t-test (*p < 0.05; **p < 0.01; 
***p < 0.001). When more than 2 groups were compared, one-way analysis of variance (ANOVA, 
P < 0.05) followed by Newman-Keuls multiple comparisons test (p < 0.05) was performed. Thus, 
in the time course experiments, differences between fish groups for each time point were analyzed 
by Student t-test and differences among time points for each fish group were analyzed by ANOVA. 




3.3.1 Inhibition of twist3 Impairs Adult Zebrafish EOM Regeneration 
Twist TFs are expressed during zebrafish embryogenesis and regulate craniofacial skeletal 
development [23, 28]. They are also known to be master regulators of stem cells [29, 30]. Given 
the need to generate dedifferentiated myoblasts in order to regenerate EOMs, we hypothesized that 
knock-down of Twist TFs would impair EOM regeneration. Translation blocking MOs 
significantly decreased protein levels of all Twist TF proteins in embryos (twist1a/b and twist2) 
and adult EOM (twist3) (Figure 3.1 H-K). To test the effect of twist TF knockdown on EOM 
regeneration, we performed MO injections and electroporation 4 hours prior to myectomy of the 
right LR muscle. At 8 days post injury (dpi), control MO injected muscles were fully regrown as 
expected (Figure 3.1 A-A") [10]. The twist1a, twist1b, and twist2 MO injection groups also 
displayed full regeneration at 8 dpi (Figure 3.1 B-D"). In contrast, twist3 injected muscles at 8 dpi 
were significantly shorter than other groups (Figure 3.1 E-E", F). 
To determine if this effect was inhibition or just delay of regeneration, we observed the 
twist3 MO injected group at 21 dpi, approximately three times longer than the typical regeneration 
time for zebrafish LR post myectomy [10]. At 21 dpi, the length of the regenerated muscle in the 
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twist3 knockdown group remained significantly shorter than the control group (Figure 3.1 G), 
suggesting true inhibition of regeneration. Co-injection of twist1a/b, twist2, and twist3 MOs did 




Figure 3.1: Inhibition of Twist3, but not other Twist TFs, impairs muscle regeneration.  
To knock down Twist TFs, lissamine-tagged MOs (red) against twist 1a, 1b, 2, and 3 were 
microinjected into Tg(α-actin::EGFP) (green) fish muscles 4 h prior to myectomy. (A-E'') MO 
injected fish were shown. (H-J) Knockdown effect of twist 1a/b, and twist2 MO was validated in 
embryos by Western blot. (K) Knockdown effect of twist3 MO was validated in EOM by 
Western blot. (F) The length of regenerating muscle was measured as described; values are 
averages ±SEM (one-way ANOVA, p<0.05 between group a and b, control:n=6, twist1a: n=4, 
twist1b: n=5, twist2: n=6, twist3: n=7). (G) Twist3 MO inhibits but does not delay EOM 
regeneration; mixture of all 4 Twist TFs MOs or single control and twist3 MO were 
microinjected into α-actin-EGFP fish muscles 4 h prior to myectomy. The length of regenerating 
muscle was measured as described; values are averages ±SEM (one-way ANOVA, p<0.05 
between group a and b, control: n=8, twist1/2/3: n=4, twist3: n=5). White arrows marked the 





3.3.2 Electroporation of EOMs Alone Does Not Stimulate Proliferation 
Electroporation of MOs to modify protein expression has been widely utilized in both in 
vitro and in vivo studies in multiple tissues [31-35]. Skeletal muscle is a favored target tissue for 
this technique and electroporation significantly improves the transgene efficiency [35]. However, 
there remains concern about muscle damage and subsequent repair associated with electroporation 
process [35, 36].  In order to exclude electroporation-induced damage and cellular reprogramming 
as a confounding variable, we assessed levels of proliferation between either electroporation or 
myectomy alone or in combination. We found that electroporation alone did not significantly 
induce cell proliferation; only ~2.5% of total myocytes were proliferating cells (EdU-positive vs 
DAPI-positive; Figure 3.2). In contrast, both cut muscle (i.e. injury only) combined treatment 
muscle (i.e. cut and electroporated) showed 3 times greater induction of cell proliferation 
compared to electroporation alone (~7.5%; Figure 3.2). We therefore concluded that, although 
electroporation does cause muscle damage and induce cellular proliferation, its extent is 
insignificant compared to our standard injury procedure (i.e. 50% myectomy of the lateral rectus) 






Figure 3.2: Electroporation does not cause significant damage of EOM. 
Boxplot of the percentage of proliferating nuclei (EdU) out of all nuclei (DAPI), in three 
different treatment groups: cut only (blue), both cut and electroporation (yellow), and 
electroporation only (red). The boxplot displays the minimum, 25th percentile, median, 75th 
percentile, and maximum for the groups. p<0.001 between two statistic groups a and b by 
ANOVA. 
 
3.3.3 Inhibition of twist3 Reduces Cell Proliferation During Muscle Regeneration 
Adult zebrafish EOM regeneration requires myocyte dedifferentiation, followed by a 
proliferative burst at 24-48 hpi [10]. After generating a sufficient number of myoblasts, cells then 
migrate, re-differentiate into myocytes and fuse into myotubes [10]. Based on the observed 
inhibition of regeneration in twist3 MO-injected fish, and the known roles of Twist TFs in stem 
cell biology, we hypothesized that twist3 would be important in early dedifferentiation steps 
leading to proliferation. 
First, we determined the timing of twist3 gene expression level by Western blot and found 
a 1.5-fold induction of twist3 as early as 3 hpi (Figure 3.3 I, J). Next, we utilized an EdU 
incorporation assay to test the number of proliferating myoblasts post-injury, since proliferation 
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of dedifferentiated myoblasts represents the final step of the reprogramming process [25, 37]. We 
found that the percentage of proliferating myoblasts (EdU-positive nuclei) in twist3 MO-injected 
fish was significantly reduced at both 24 and 48 hpi compared to control MO-injected fish (Figure 
3.3 B, D, F, H). In contrast, twist3 MO did not inhibit proliferation during embryonic development, 
since the phosphorylation of histone H3 (proliferation marker) was increased instead of decreased 
by twist3 MO (Figure 3.6), suggesting that the role of twist3 in EOM myocyte dedifferentiation 
was not reflective of a general role in cell proliferation. The induction of phosphorylation of 
histone H3 may due to the delay of development caused by twist3 MO injection (Figure 3.7 D’”). 
During regeneration of control MO-injected muscles, myofibers in the control group lost 
Z-band architecture and became mesenchyme-like in appearance at 24 hpi (Figure 3.3 A’, A”). It 
was difficult to distinguish individual myofibers and the morphology became increasingly more 
mesenchymal at 48 hpi (Figure 3.3 E’, E”) [10]. In contrast, in twist3 MO-injected muscles, 
myocytes maintained a differentiated myofiber morphology and Z-band architecture was clearly 
shown at 24 hpi (Figure 3.3 C’, C”). Some myofiber structure remained and Z-bands could be seen 
in some myofibers at 48 hpi (Figure 3.3 G’, G”). Taken together, these data suggest that twist3 






Figure 3.3: Inhibition of Twist3 impairs myocyte reprogramming and proliferation. 
The role of Twist3 in myocyte reprogramming and proliferation at 24 and 48 hpi was assessed by 
injecting Tg(α-actin::EGFP) fish with twist3 MO. Morphology of myocytes was shown using 
DIC images (A, C, E, G),highlighted in higher magnification (A’, C’, E’, G’) and illustrated in 
schematic diagram (A”, C”, E”, G”; solid line: outline of muscle; dash line: approximate outline 
of muscle; dotted pattern: mesenchyme-like myocytes; long light blue line: myofiber; short 
vertical strips: Z-band architecture). (B, D, F, H) Proliferating myoblasts were stained by EdU 
incorporation. EdU: magenta; DAPI: blue; Yellow arrows: positive Edu staining nuclei and 
corresponding DAPI channel. (I, J) Western blot analysis for Twist3 protein expression during 
EOM regeneration; values were averages ±SEM (t-test, p<0.0001 between control and 3hpi, 
n=3). (K, L) Cell proliferation in injured muscle was significantly less in Twist3 MO injection 
group compared with control group at both 24 and 48 hpi. (24 hpi, control: n=8, twist3 MO: n=7; 
48 hpi, control: n=6, twist3 MO: n=5) Scale bar: 50 µm, **p<0.01, ****p<0.0001. 
 
 
3.3.4 Twist3 is Involved in EOM Regeneration Via A Shared Pathway with Fgf 
We next investigated the mechanism through which twist3 promotes EOM regeneration. 
Twist is required for the proper function of the Fgf-signaling pathway [38]. Our previously 
published study highlighted the important role of Fgf signaling in zebrafish EOM regeneration 
[25]. Hence, we tested the hypothesis that twist3 promotes regeneration via Fgf signaling. In order 
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to test this hypothesis, we combined twist3 MO injection with pharmacological inhibition of Fgf 
using su5402, an Fgf-receptor inhibitor [25]. Both su5402 and twist3 MO injection alone 
significantly decreased regenerated muscle length as expected (Figure 3.4 D-I). Combining su5402 
treatment and twist3 MO injection inhibited regeneration, but no additive/synergistic effect was 
observed compared to MO injection or su5402 alone (Figure 3.4 J-M) Twist3 protein level was 
higher in the su5402 group compared with the control group at 3 hpi (Figure 3.4 N), suggesting a 
negative feedback loop existing between twist3 and Fgf pathways. That is, inhibition of Fgf 
induced the expression of twist3. In addition, the induction of twist3 could not overcome the effect 
of Fgf inhibition (Figure 3.4 J-L). Taken together, these data suggest that Fgf is an upstream – but 
not direct - regulator of twist3, and that Fgf has other downstream targets involved in muscle 






Figure 3.4: Inhibition of Fgfr and twist3 do not have an additive effect on EOM 
regeneration. 
Myectomized Tg(α-actin::EGFP) fish were treated with su5402 (D-F), or injected with twist3 
MO (G-I), or treated with su5402 and injected with twist3 MO (J-L) compared with DMSO 
treatment and control MO injection (A-C). (M) All the experiment groups demonstrated 
significantly inhibited muscle regeneration, with no additive effect detected by combination of 
two treatments at 8 dpi. (p, pituitary; e, eye; Scale bar: 250µm, p<0.05 between two statistic 
groups a and b by ANOVA, control MO/DMSO: n=7, control MO/su5402: n=10, twist3 







Figure 3.5: Twist3 role during EOM regeneration. 
Following myectomy injury, twist3 expression is elevated and promotes myocytes cell 
reprogramming and dedifferentiation. The known role of Fgf combined with our results (Figure 




Cellular reprogramming from a more- to less-differentiated state requires coordinated 
changes in chromatin, gene expression and cellular architecture, driven by altered functionality of 
key transcription factors [39, 40]. Because of their role as master regulators of stem cells and in 
embryonic craniofacial development, we decided to use our unique zebrafish EOM regeneration 
model to test whether twist TFs play a role in EOM myocyte dedifferentiation.  
In adult zebrafish, EOM regeneration begins with myocyte reprogramming - an EMT 
process - followed by cell cycle reentry, proliferation, and migration of the dedifferentiated 
myoblasts, and eventually re-differentiation into myocytes that fuse to form myofibers [10]. Our 
long-term goal is to understand regulations of cell identity and fate, by understanding the early 
steps of EOM myocytes reprogramming dedifferentiation.  
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Twist TFs belong to the basic helix-loop-helix (bHLH) family that is important for the 
regulation of cell fate decision and differentiation [41] and EMTs [42]. Twist TFs are also 
considered master regulators of stem cells in that they are important to maintaining the stem cell 
state [21, 29, 30]. In our regeneration model, twist TF knockdown impaired muscle regeneration 
by inhibiting myocyte reprogramming, revealing an early role for Twist that is consistent with the 
early induction of expression following injury and with Twist TF’s role in EMT.  Interestingly, 
this effect was specific to twist3 (homolog of mammalian twist2) and none of the other paralogs, 
revealing evolutionary sub-functionalization in the context of adult tissue regeneration.  
It has been reported that Twist is involved in adult muscle regeneration in both Drosophila 
and mice. In Drosophila, persistent twist expression is a marker of embryonic precursors for adult 
muscle [43]. Twist is also required for adult Drosophila myogenesis [18]. In mouse skeletal 
muscle, twist expression is quickly elevated after injury [20]. In addition, murine Twist2 (an 
orthologue of Zebrafish twist3)-dependent progenitor cells contribute to muscle regeneration [21]. 
In adult zebrafish, twist1a and twist1b are involved in heart regeneration [44, 45]. Our study 
represents the first investigation of twist within adult zebrafish skeletal muscle regeneration, and 
our results suggest that promoting muscle regeneration may be an evolutionarily-conserved 
function of twist TFs.  
The role of twist1 in zebrafish development has been extensively studied. As EMT 
transcription factors, twist1 are involved in neural crest migration, which undergo an EMT to give 
rise to many different derivatives [46]. Regulated by thyroid hormone [47], retinoic acid (RA)[48], 
Wnt [49], Bmps and Id2a [28] signaling pathways, Twist 1a/b is required for proper development 
of craniofacial cartilage and skeleton [50], with Runx2 a known downstream target [13, 14]. 
Twist1 is also involved in blood vessel sprouting in zebrafish embryos [51]. Like twist1, twist2 is 
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also involved in bone formation regulated by RA [48]. Despite their significant peptide similarity, 
expression locations of four twist TFs differ significantly from each other, suggesting a 
considerable divergence of regulatory controls [52, 53]. This is supported by our findings that 
different twist TFs are involved in EOM regeneration and development. Twist3 is involved in 
zebrafish EOM regeneration but not development. In embryos with twist3 knockdown, EOM 
development appeared normal, although the muscle appeared longer and thinner, possibly due to 
a severe bulging eye phenotype (Figure 3.7 D-D'''). EOMs also developed normally after twist1a/b 
knock-down (Figure 3.7 B-B"). In contrast, while muscle fibers could be identified following 
twist2 knockdown (highlighted by actin-GFP), they failed to form a normal EOM pattern. It was 
difficult to differentiate the 6 pairs of EOMs based on insertion position (Figure 3.7 C-C') 
compared with control fish (Figure 3.7 A-A'). Instead of normal insertion patterns, muscles seemed 
to “wrap around” the globe (Figure 3.7 C"). In embryos, twist2 knockdown impaired EOM 
formation as early as 48 hpf (Figure 3.8 B-B"). This finding reveals a key difference between 
zebrafish embryonic development and regeneration, suggesting that regeneration is not a simple 
recapitulation of developmental programs but rather a distinct program, albeit one that utilizes 
many of the same building blocks. 
An important limitation of this study is the use of MOs to knockdown gene expression. 
MOs have been used widely in a variety of experimental models, such as Xenopus, zebrafish and 
other organisms [54]. However, in embryo research, their use has been largely supplanted by 
CRISPR/Cas9 genetic engineering because of concerns about MO knockdown efficiency and off-
target effects [55]. It should be noted that the phenotypic differences between mutants 
(CRISPR/Cas9) and morphants (MO knockdown) may due to the natural activation of genetic 
compensation induced in mutants [56]. Nevertheless, for knocking down gene expression in select 
89 
 
adult tissue, direct electroporation of MOs has no proper experimental substitute, and this 
technique has been used extensively in the adult zebrafish regeneration model [57, 58]. In this 
study, we followed the guidelines for use of MOs in zebrafish [55], most importantly validating 
multiple MOs and assessing reduction in protein level using Twist antibodies (Figure 3.1). 
Furthermore, since knockdown of different Twist family members resulted in specific phenotypic 
differences, our results are most consistent with a specific phenotypic effect rather than off-target 
effects. Ultimately, there are no alternative techniques for knocking down gene expression of a 
specific gene in a specific extraocular muscle, and hence electroporation of MOs represents the 
state of the art for these experiments.  
Twist TFs are critically important to both embryonic development and cancer. The 
involvement of Twist in cancer includes EMT during metastasis [42, 59-61], as well as 
maintenance of cancer stem cells [42, 62-65]. In our study, injured EOMs in the twist3 knock-
down group do not de-differentiate properly, consistent with an early role for Twist in 
reprogramming and EMT (i.e. muscle-to-mesenchymal transition).  The similarities between 
cellular dedifferentiation and cancer have been previously noted [66-69], and our data provide 






Figure 3.6:  Twist3 MO does not inhibit cell proliferation during embryo development. 







Figure 3.7: Twist2 regulates EOM development in zebrafish. 
Tg(α-actin::EGFP) embryos that were injected with twist 1a/b, 2, or 3 MO at the one- to four-
cell state demonstrated EOM formation at 5 dpf from dorsal (B-D), lateral (B'-D'), Ventral (B''-
D''), and phenotype (B'''-D''') compared with control embryos (A-A'''). SO: Superior Oblique, SR: 
Superior Rectus, LR: Lateral Rectus, IO: Inferior Oblique, IR: Inferior Rectus. Asterisk: 






Figure 3.8: Twist2 delays EOM development in zebrafish. 
Tg(α-actin::EGFP) embryos that were injected with twist2 MO at the one- to four-cell state 
demonstrated EOM formation at 48 or 72 hpf from dorsal (B, D), lateral (B'-D'), and ventral (B''-
D'') compared with control embryos (A-A'', C-C''). SO: Superior Oblique, SR: Superior Rectus, 
LR: Lateral Rectus, IO: Inferior Oblique, IR: Inferior Rectus. Red arrow: incorrectly inserted 
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Chapter 4: Role of Evc2/Limbin in midfacial development4 
 
4.1 Introduction 
Ellis-van Creveld (EvC) syndrome is an autosomal recessive chondroectodermal dysplasia 
[1]. Affected individuals display a wide spectrum of symptoms including dwarfism, postaxial 
polydactyly, nail dysplasia, atrial septal or atrioventricular septal cardiovascular defects, and 
dental anomalies [1, 2]. Genetic studies have allowed identification of two causative genes for EvC 
syndrome, EVC and EVC2, and homozygous mutations in either have been linked to two-thirds of 
EvC patients [3]. Additionally, EvC syndrome [4] has been characterized as a ciliopathy because 
the EVC and EVC2 proteins are intracellularly localized at the bottom of the primary cilium, where 
they form a heterotrimeric protein complex with SMO and transduce Hedgehog signaling [5, 6]. 
Our previous studies interestingly identified the bovine ortholog LIMBIN/EVC2 as a causative 
gene for chondrodysplasia in Japanese brown cattle [7]. Recent studies also identify 
LIMBIN/EVC2 mutations in dwarf Tyrolean Grey cattle [8]. These two studies suggest an 
evolutionarily conserved function of EVC2 among different species.  
Multiple studies have linked EvC syndrome with a wide range of craniofacial abnormalities 
including an enlarged skull, depressed nasal bridge, class II skeletal pattern with or without 
mandibular prognathism, and a skeletal open bite. Patients less frequently exhibit normocephaly 
with minimal facial defects and instances of class I skeletal patterns [9-13]. The variation of mid-
 
4 Published as Kulkarni A, Louie KW, Yatabe M, de Olivera Ruellas AC, Mochida Y, Cevidanes 
LHS, Mishina Y, Zhang H. 2018. A cilliary protein EVC2/LIMBIN plays a critical role in the 
skull base for mid-facial development. Frontiers in Physiology 9: 1484.  
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facial defects reported in EvC patients prompted the generation of mouse models for EvC 
syndrome that facilitate characterization of affected mid-facial development and associated 
pathological mechanisms.   
We and others have used both Evc and Evc2 mutant mice to characterize different aspects 
of abnormal development [5, 14, 15]. Generating our own Evc2 mutant mice enabled us to 
characterize the pathological mechanisms leading to abnormal appendicular bone and 
hypomorphic enamel development [15-17]. Our subsequent studies further demonstrated the 
expression of Evc2 in the mid-facial regions [18] and mid-facial defects in Evc2 global mutant 
mice [19]. We most recently employed a conditional, Cre-mediated approach towards deleting 
Evc2 in a neural crest-specific manner. In a comparison between global and P0-Cre-mediated Evc2 
mutants, we reported that at postnatal day 8 (P8): (1) Evc2 P0 mutants somewhat recapitulate 
craniofacial and tooth phenotypes exhibited by Evc2 global mutant mice and that (2) many mid-
facial defects identified in the Evc2 global mutants are not present in the Evc2 P0 mutants [20]. 
This latter finding was surprising and warranted further study since P0-Cre predominantly targets 
the mid-facial region where Evc2 is, similarly, expressed. 
To identify a pathological mechanism leading to the mid-facial defects in Evc2 mutant 
mice and EvC patients, we compared outcomes of Evc2 deletion within the neural crest-derived 
tissues of two similar, but not identical, neural crest-specific Cre lines: P0-Cre and Wnt1-Cre. 
Recombination efficiency and craniofacial deficiencies varied between mouse lines and facial 
region. Specifically, although both Cre lines showed indistinguishable recombination efficiency 
within the mid-facial bones, Wnt1-Cre-mediated excision of Evc2 resulted in a more robust mid-
facial hypoplasia. Conversely, those two Cre lines showed differential recombination efficiencies 
within the anterior portion of the skull base. Analyses of these two mutant mice lines highlights 
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the critical function of the skull base during postnatal mid-facial development and uncovers the 
pathological mechanisms whereby the shortened skull base, due to Evc2 loss of function within 
those bones, leads to characteristic EvC mid-facial defects.  
 
 
4.2 Materials and Methods 
4.2.1 Animal Model 
Animals were maintained and used in compliance with the Institutional Animal Care and 
Use Committee (IACUC) of the University of Michigan in accordance with the National Institutes 
of Health Guidelines for Care and Use of Animals in research, and all experimental procedures 
were approved by the IACUC of the University of Michigan. Evc2 floxed mice used in this study 
were generated by our group and reported previously [15]. Neural crest-specific Evc2 mutant mice 
were generated by crossing Evc2 floxed mice either with Wnt1-Cre mice [21] or with P0-Cre mice, 
C57BL/6J-Tg(P0-Cre)94Imeg (ID 148), which was provided by Dr. Kenichi Yamamura [22]. All 
mice were maintained in a mixed background of C57BL6/J and 129S6 and were crossed and 
maintained in our semi-closed mouse colony for at least 5 years.  
 
4.2.2 Micro-CT (μCT) 
Micro-CT scanning of fixed heads was performed at the University of Michigan using a 
Micro-CT Core (µCT100 Scanco Medical, Bassersdorf, Switzerland). Scan settings were as 
following: voxel size 12 µm, 55 kVp, 109 µA, 0.5 mm AL filter, and integration time 500 ms.  
 
4.2.3 Cephalometric Analysis 
Lateral radiographic films were taken according to previously published methods. The 
linear and angular cephalometric analyses followed the parameters outlined in a previous report 
[23] with certain modifications (Table 4.1). An additional landmark (Br) was placed on the 
bregma, the point of intersection between the sagittal and coronal sutures. The distance from the 
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bregma (Br) to the most posterior point of the skull (Po) was measured, denoted by the abbreviation 
Po-Br. The angle ABrL/PoBrL was also measured between the Po-Br segment described above 
and the A-Br segment, which stretches the combined length of the nasal and frontal bones. This 
angle was used to emulate the concavity of the skull superficial to the cranial vault. Overall, 15 
landmarks (Table 4.1) were placed in each sample and a total of 20 linear measurements and 15 
angular measurements were taken (Table 4.1).  
 
 







4.2.4 Image Acquisition, Segmentation, and Surface Model Analysis 
We performed shape comparisons of the nasal, frontal and parietal bones between controls 
and mutants (Evc2 fl/fl; Wnt1-Cre). The surface model for each bone was generated based on the 
micro-CT data, using ITK-SNAP (open-source software developed by grants and contracts from 
the U.S. National Institutes of Health, www.itksnap.org). For shape comparisons, landmarks were 
placed on the individual bone surfaces by using “modules” developed in 3D Slicer (open-source 
software, www.slicer.org). There 3D Slicer modules were then used to both superimpose the two 
bones based on the landmarks (CMF Registration) and to visualize shape differences (Shape 
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Population Viewer). Model superimpositions for the mid-line region of the skulls were carried out 
using 3D Slicer with the following landmarks on the interparietal bones and basioccipital bones: 
right and left anterolateral tips of the interparietal bone, cross point between the median line and 
the line which connects left and right anterolateral tip of the interparietal bone, and posterior tip of 
the interparietal bone. Model superimpositions for nasal, frontal and parietal bones were carried 
out using 3D Slicer with landmarks on the right and left of anterolateral and posterior tips of each 
bone. Superimpositions were achieved by posterior registration of the two models. The length of 
the skull base and each indicated segment of the skull base were determined by assessing the linear 
distance between the most anterior midline point of and the most posterior point on the midline 
region of the skull base or the indicated segment of the skull base using a module program, Q3DC, 
in 3D Slicer. 
 
4.2.5 Statistical Analysis 
The Mann-Whitney U test was done by using SPSS21.0 to evaluate the linear and angular 




4.3.1 Evc2 Mutation Within Neural Crest Cells Leads to Craniofacial Abnormalities 
Our previous studies indicated that global Evc2 mutation led to retarded growth and 
significantly affected both body and head size [15, 19]. To better characterize the function of Evc2 
in craniofacial development, we generated mutant mice with Evc2 deleted in the neural crest-
derived cells. Both P0-Cre and Wnt1-Cre mediate nearly identical recombination efficiencies 
within the mid-facial region [21, 22] (our own comparisons, data not shown). However, Evc2 
deletion mediated by the P0-Cre (Evc2 fl/fl; P0-Cre, abbreviated as Evc2 P0 mutants) leads to an 
overall shortened head and delayed mandibular incisor eruption at postnatal day 8 (P8) (Figure 4.1 
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A). In Evc2 P0 mutants at P28, we observed less pronounced reductions in head and incisor lengths 
(Figure 4.1 B). Evc2 deletions mediated by Wnt1-Cre (Evc2 fl/fl; Wnt1-Cre, abbreviated as Evc2 
Wnt1 mutants) did not affect head length at P8 but did lead to shortened head and hypomorphic 
incisor dimensions at P28 (Figure 4.1 A and B). Unlike Evc2 global mutant mice, there was no 
apparent neonatal or postnatal death observed in either Evc2 P0 or Evc2 Wnt1 mutant groups at 
the above time points. Furthermore, in both types of Evc2 cKO, at P8 and P28, we observed 
insignificant gender-specific differences, particularly in the parameters characterizing mid-facial 
defects. Lack of gender-specific observations is consistent with previous studies and we, therefore, 
did not match genders in our comparative analyses [24, 25]. Therefore we combined both genders 





Figure 4.1: Gross morphologies of heads from Evc2 P0 mutants and Evc2 Wnt1 mutants. 
Images represent P8 (A) and P28 (B). 
 
 
4.3.2 Evc2 P0 Mutants Showed More Aspects of Mid-Facial Defects than Evc2 Wnt1 
Mutants at P8 
To characterize the abnormal craniofacial development observed in both Evc2 P0 mutants 
and Evc2 Wnt1 mutants, we examined the linear and angular dimensions from lateral 
cephalometric radiographs. In Evc2 P0 mutants at P8, the lateral cephalometric analysis indicated 
abnormalities in the incisors, skull base, and mid-facial regions. We specifically found decreases 
in growth axes of the upper face (E-Iu), viscerocranial length (E-Bu), erupted upper incisor length 
(Pr-Iu), erupted lower incisor length (Id-Ii), distance between the first molar and incisor in 
mandible (Ml-Ii), length of anterior cranial base (So-E), neurocranial length (Po-E), the distance 
between the first molar to the most posterior point (Po-Mu), and total skull length (Po-A), 
respectively (Figure 4.2 A, Table 4.2). These phenotypic observations recapitulate many of the 
mid-facial defects of the Evc2 global mutants that we previously reported (Badri et al. 2016a). 
Additionally, we found a shallow mid-facial region in the Evc2 P0 mutants, as evidenced by 
decreased angle measures in nasal bone to cranial base (ANL/SoEL), maxilla-premaxilla to cranial 
base (MuBuL/SoEL), maxilla-premaxilla to cranial vault (MuBuL/PoEL), upper incisors to cranial 
base (BuEL/SoEL), and angle of cranial vault (ABrL/PoBrL), respectively (Figure 4.2 B, Table 
4.2). 
Similar analyses of the Evc2 Wnt1 mutants revealed abnormalities limited to the incisors 
and the skull base. We detected decreases in erupted upper incisor (Pr-Iu), erupted lower incisor 
(Id-Ii), and distance between the first molar and incisor in the mandible (Ml-Ii), respectively 
(Figure 4.2 C, Table 4.2). Similar to Evc2 P0 mutants, these phenotypic observations recapitulate 
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some characteristics of Evc2 global mutants [18, 19]. Additionally, we also found a shortened skull 
base in the Evc2 Wnt1 mutants, as evidenced by decreased length in the anterior skull base (So-E) 
(Figure 4.2 C). Although most of the linear measurements showed no significant differences 
between control and Evc2 Wnt1 mutants, we observed a slanted mid-facial region in the Evc2 Wnt1 
mutants, supported by the following decreased angle measures: the nasal bone to the skull base 
(ANL/SoEL), the maxilla-premaxilla to the skull base (MuBuL/SoEL), the premaxilla to the 
cranial base (PrEL/SoEL), the premaxilla to the cranial vault (BuEL/PoEL), and the angle of the 
cranial vault (ABrL/PoBrL) (Figure 4.2D). In summary (Table 4.2), at P8 both Evc2 P0 mutants 
and Evc2 Wnt1 mutants showed fewer aspects of mid-facial defects compared to Evc2 global 
mutants. Of the two types of conditional mutants, Evc2 P0 mutants showed more severe and 






Figure 4.2: Differential mid-facial defects between Evc2 P0 mutants and Evc2 Wnt1 
mutants at P8. 
Lateral x-ray cephalogram indicates the linear (A) and angular (B) measurements with 
significant differences between controls and Evc2 P0 mutants. Lateral x-ray cephalogram 
indicates the linear (C) and angular (D) measurements with significant differences between 
controls and Evc2 Wnt1 mutants. Graphs indicate the linear and angular values of the 
measurement with significant differences. (N=7; *, p<0.05; and **, p<0.01) 
 
 
Table 4.2: Summary of phenotypic spectrums of Evc2 global mutants, P0 mutants and 
Wnt1 mutants.  
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Orange box, significant differences detected in Evc2 P0 mutants. Blue box, significant difference detected 







4.3.3 Evc2 Wnt1 Mutants Showed More Aspects of Mid-Facial Defects than Evc2 P0 
Mutants at P28 
Mouse cranial growth rate  peaks and reaches 80% of its adult length within the first month 
[24, 25]. We therefore performed similar lateral cephalometric analyses at P28 but, unlike analyses 
at P8, observed more widespread craniofacial deficiencies in Evc2 Wnt1 mutants compared to Evc2 
P0 mutants. In Evc2 P0 mutants we found significant decreases in: viscerocranial length (E-Bu 
and E-Pr), distance between molar and incisor in maxilla (Mu-Pr), erupted upper incisor length 
(Pr-Iu), erupted lower incisor length (Id-Ii), length of anterior skull base (So-E), neurocranial 
length (Po-E), distance between the first molar to the most posterior point (Po-Mu), and total skull 
length (Po-A) (Figure 4.3A). The only significant angle difference was a decreased angle of cranial 
vault (ABrL/PoBrL) in the Evc2 P0 mutants (Figure 4.3 B).  
In contrast to the Evc2 P0 mutants, Evc2 Wnt1 mutants at P28 displayed a more severe and 
widespread decreases in their craniofacial linear measurements. We found significant decreases in 
nasal bone length (A-N), nasal bone height (E-Mu), viscerocranial length (E-Bu) and (E-Pr), 
relative position of pre-maxilla to cranium (N-Pr), distance between molar and incisor in maxilla 
(Mu-Pr), palatal length (Mu-Bu), length of anterior cranial base (So-E), neurocranial length (Po-
E), length of posterior cranium (Po-Br), and total skull length (Po-A). Similar to Evc2 Wnt1 
mutants at P8, we also observed shortened erupted upper (Pr-Iu) and lower (Id-Ii) incisors, and 
decreased distance between molar and incisor in mandible (Ml-Ii) (Figure 4.3 C). Consistent with 
the slanted mid-facial region in the gross morphologic observations, we also detected decreased 
angle measures of nasal bone to cranial base (ANL/SoEL), premaxilla to cranial base 
(PrEL/SoEL), premaxilla to cranial vault (BuEL/PoEL), and the angle of the cranial vault 
(ABrL/PoBrL), respectively (Figure 4.3 D). Overall, Evc2 Wnt1 mutants showed severely affected 
110 
 
mid-facial bones and a more slanted mid-facial region at P28 when compared to both control and 
Evc2 P0 mutant counterparts.  
In Table 4.2, a series of linear and angular defects detected in Evc2 P0 mutants and Evc2 
Wnt1 mutants (present study) are compared with those found in Evc2 global mutants [18, 19]. At 
P7/P8, comparisons in linear measurements revealed that all tooth-associated abnormalities 
detected in Evc2 P0 mutants and Evc2 Wnt1 mutants were also detected in the Evc2 global mutants. 
Additionally, nasal bone length (A-N), viscerocranial height (E-Mu), and mandibular lingual 
alveolar bone length (Ml-Bl) were significantly shorter in the Evc2 global mutants than in controls, 
whereas these characteristics were normal in both Evc2 Wnt1 mutants and Evc2 P0 mutants. In the 
angular measurements, we found that lower incisor inclination (MlIiL/IdIiL) and upper incisor 
inclination (MuPrL/PrIuL) were increased in the Evc2 P0 mutants and Evc2 Wnt1 mutants but not 
in the Evc2 global mutants. At P21/P28, all linear measurement differences detected in Evc2 Wnt1 
mutants were detected in Evc2 global mutants. Of these, decreased palatal length (Mu-Bu) and 
length of posterior cranium (Po-Br) were not detected in the Evc2 P0 mutants. These results reflect 
subtle phenotypic dissimilarities between mutants at P28 that are not apparent at P8. In the P28 
angular measurements, we found that defective nasal bone to cranial vault (ANL/PoEL), maxilla-
premaxilla to cranial base (MuBuL/PoEL), and upper incisor to cranial vault in Evc2 P0 mutants, 
but not in the Evc2 Wnt1 mutants, whereas defective upper incisor inclination (MuPrL/PrIuL) and 
lower incisor inclination (MlIiL/IdIiL) was observed in the Evc2 Wnt1 mutants but not in the Evc2 
global mutants. Except for the decreased angle of cranial vault (ABrL/PoBrL), there were no other 






Figure 4.3: Differential mid-facial defects between Evc2 P0 mutants and Evc2 Wnt1 
mutants at P28. 
Lateral X-ray cephalogram indicates the linear (A) and angular (B) measurements with 
significant differences between controls and Evc2 P0 mutants. Lateral x-ray cephalogram 
indicates the linear (C) and angular (D) measurements with significant differences between 
controls and Evc2 Wnt1 mutants. Graphs indicate the linear and angular values of the 
measurement with significant differences. (N=7; *, p<0.05; and **, p<0.01) 
 
 
4.3.4 Loss of Evc2 Expression in Neural Crest-Derived Cells Severely Affects Head Shape 
and Mid-Facial Bone Shapes 
Particularly at P28, Evc2 P0 mutants showed very limited angular defects. To better 
appreciate the impacts of Evc2 mutation on the overall skull shape at P28, we: 1) generated 3D 
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surface models from micro-CT data for the midline portion of the controls, Evc2 P0 mutants, and 
Evc2 Wnt1 mutants at P28 and 2) registered the skulls at the most posterior region (Figure 4.4 A). 
Registration of each pair of skulls revealed nearly no shape differences in the interparietal and 
basioccipital bones (i.e. tissues negative for neither P0-Cre nor Wnt1-Cre expression). When we 
individually superimposed nasal, frontal and parietal, respectively, bones, respectively, using Evc2 
P0 mutants and Evc2 Wnt1 mutants with corresponding controls, we did not see noticeable size 
differences (Figure 4.4 B). This suggests that there was no overt overall growth retardation since 
general growth retardation would affect all bones. Morphometric comparison, however, revealed 
mutant-specific structural differences. Evc2 Wnt1 mutants had a more shortened and downward-
angled facial region than Evc2 P0 mutants (Figure 4.4 A). Since the skull base connects the facial 
region with the posterior part of the skull, the extent of skull base linear differences may directly 
result in angular measurement differences in Evc2 Wnt1 and Evc2 P0 mutants, respectively. To 
visualize the potential shape or scaling differences within each individual bone, we digitally 
extracted nasal, frontal, and parietal bones separately and superimposed control surface models 
with corresponding mutant samples (Figure 4.4 B). Superimpositions of individual bones revealed 
shape differences in all nasal, frontal, and parietal bones (Figure 4.4 B). Most strikingly, in the 
parietal bones (non-neural crest derived), we detected deviations in the anterior regions, in which 
the mutant surfaces “stuck out” of the control surfaces (red color in Figure 4.4 B). Evc2 Wnt1 
mutants have more severely affected parietal bones than Evc2 P0 mutants. Three other mutant 
skulls from each mutant group showed similar patterns when compared with littermate controls 
(Figure 4.7). When we compared four littermate controls within the Evc2 P0 mutant group or four 
littermate controls within the Evc2 Wnt1 mutant group using the same standard, almost all areas 
showed green color indicating that surface structures of those bones are highly consistent among 
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controls (Figure 4.7, one pair of comparison for each group is shown). The defective skull bones 
in Evc2 mutants likely reflect the shortened skull base and resultant shortened and downward-
angled mid-facial region. Therefore, the more severely affected parietal bones in the Evc2 Wnt1 
mutants (compared to Evc2 P0 mutants) are likely due to the more severely affected skull base in 








Figure 4.4: Evc2 cKO mutants demonstrate skull shape and mid-facial shape differences. 
A. Mid-sagittal planes were generated based on the micro-CT scans of the controls (Blue), Evc2 
P0 mutants (red) and Evc2 Wnt1 mutants (red). Models of skulls from mutants and 
corresponding controls were then superimposed at the occipital bones of the skull. Blue and red 
arrows are spanning the entire regions of the skull bases in controls and mutants respectively. B. 
Nasal, frontal and parietal bones from P28 Evc2 P0 mutants and Evc2 Wnt1 mutants were 
superimposed with corresponding skull bones from P28 controls. Pictures shown represent 
comparisons within indicated mutants with corresponding controls. Color indicates the distances 
the mutants bone surface protruding out of the control surface at the indicated region.  
 
 
4.3.5 The Differential Early Fusion of the Presphenoidal Synchondrosis Leads to the 
Differentially Shortened Skull Base in Evc2 P0 and Evc2 Wnt1 Mutants 
The skull base is a unique structure that connects multiple bones in the skull and has a 
significant influence on facial growth, particularly in the mid-facial region [26]. Our studies 
demonstrated that Evc2 is expressed in both intersphenoidal synchondrosis (ISS) and the spheno-
occipital synchondrosis (SOS) (Figure 4.8). Quantification of the skull base length revealed that, 
compared to controls, skull bases from Evc2 Wnt1 mutants are 20% shorter while skull bases from 
Evc2 P0 mutants are only 10% shorter at P28 (Figure 4.5 B, C, D and E, n=5, p<0.01). Elongation 
of the skull base is supported by the endochondral ossification within the ISS and the SOS. To 
investigate whether the abnormal ISS or SOS is the cause of the affected skull base elongation in 
either Evc2 P0 or Evc2 Wnt1 mutants, we generated surface models from the skull bases of Evc2 
P0 and Evc2 Wnt1 mutants respectively. At P28, we observed premature fusion of ISS in both 
Evc2 P0 and Evc2 Wnt1 mutants (Figure 4.5 B and C). However, at P8, we observed premature 
fusion of ISS in Evc2 Wnt1 mutants and partial fusion of ISS in the Evc2 P0 mutants (Figure 4.5 
B and C). These results suggest that the premature fusion of the ISS in Evc2 P0 mutants happens 
between P8 and P28, while the premature fusion of ISS in Evc2 Wnt1 happens before P8 (Figure 
4.5 C).  
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The anterior regions of the skull base are derived from neural crest cells and are the active 
sites for postnatal skull base elongation [26]. To examine if differential skull base lengths in Evc2 
P0 mutants and Evc2 Wnt1 mutants result from differential Cre recombination efficiency in the 
anterior part of the skull base, we examined the Cre recombined cells in the anterior region of the 
skull base. At E18.5, while P0-Cre leads to sporadic recombination within the chondrocytes in the 
anterior part of the skull base, Wnt1-Cre leads to nearly 100% recombination in the chondrocytes 
in the same region (Figure 4.6). These results suggest that 1) Evc2 function within the ISS is critical 
for maintaining the ISS and supporting the elongation of skull base; and that 2) differential Evc2 
deletion efficiency mediated by P0-Cre and Wnt1-Cre leads to differential impacts upon skull base 
elongation, which secondarily affects differential outcomes in mid-facial abnormalities between 








Figure 4.5: Evc2 mutants have defective skull bases. 
A. Diagram of measurements in B, C, D and E. Quantification of skull base length at P8 (B and 
D) and P28 (C and E). The length of the skull base was determined by assessing the linear 
distance shown in A. (N=5; **, p<0.01 comparing to controls). Surface models of skull bases 
were generated based on micro-CT scans of P28 (F) and P8 samples (G). Red cycles indicating 






Figure 4.6: Evc2 mutant skull base structure. 
A. Diagram to skull base structure. B. Differential Cre-dependent recombination in the skull 
bases of P0 and Wnt1 Cre lines. Indicated Cre mice were crossed with Rosa26-LacZ Cre reporter 
mice, followed by beta-galactosidase activity staining to visualize the Cre recombinant cells in 
the skull base. PS, Presphenoid bone; ISS, intersphenoidal synchondrosis; BS, Basiosphenoid 






Craniofacial abnormalities have been reported in EvC patients [1, 9, 12, 13]. Despite our 
recent studies describing mouse models that recapitulate the craniofacial abnormalities of EvC 
patients [19], the underlying pathophysiological mechanisms of these abnormalities remain largely 
unknown. In this study, we deleted Evc2 in the neural crest derived cells using P0-Cre and Wnt1-
Cre. While both of these Cre lines equally target the mid-facial region, they differentially target 
the anterior region of the skull base. Comprehensive analysis of these two types of Evc2 mutant 
lines allows us to delineate the craniofacial abnormalities due to Evc2 loss of function in the neural 
crest derived tissues and the secondary abnormalities due to the affected skull base. The results 
here are potentially applicable to understand postnatal mid-facial development in other types of 
ciliopathies.  
Compared to their global mutant counterparts, we believe that two types of Evc2 cKO mice, 
Evc2 P0 mutants and Evc2 Wnt1 mutants, are great tools in helping to elucidate the pathological 
mechanism leading to the mid-facial defects. Our phenotypic analysis at P8 and P28 indicated that 
mid-facial defects were recapitulated in Evc2 Wnt1 mutants, but less extent in Evc2 P0 mutants. 
The Evc2 P0 mutants show a smaller head (Figure 4.1 A, 2nd row) and differences in some of the 
parameters (Figure 4.2 A,B) at P8, which are consistent with our previous report [20]. However, 
many of the differences are compensated by P28 (Figure 4.1 B, 2nd row and Figure 4.3 A,B). In 
contrast, the Evc2 Wnt1 mutants show comparable size of a head at P8 but become smaller at P28 
(Figure 4.1 A,B, 4th row), and more parameters show differences at P28 than P8 (Figure 4.2 C,D 
and Figure 4.3 C,D). Those facts strongly suggest that tissues that are specifically positive for 
Wnt1-Cre mediated recombination play a critical role for post-natal mid-facial development. 
Considering the impacts of shortened skull base on the mid-facial region as shown in Figure 4.4 
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A and that loss of Evc2 leads to early fusion of ISS in Evc2 Wnt1 mutants, we believe that the 
differential Evc2 deletion efficiency mediated by P0-Cre and Wnt1-Cre at the anterior region of 
the skull base is a major reason leading to the differential mid-facial defects in these two types of 
Evc2 cKO mice. 
Differential phenotypic differences between Evc2 global mutants, Evc2 P0 mutants and 
Evc2 Wnt1 mutants suggest that different pathological mechanisms lead to various craniofacial 
defects due to Evc2 mutations. For example, viscerocranial length (E-Bu and E-Pr), erupted upper 
incisor length (Pr-Iu), erupted lower incisor length (Id-Ii), cranial base length (So-E) are due to the 
Evc2 loss of function within the neural crest cells. In contrast, the nasal bone to cranial base 
(ANL/SoEL), nasal bone to premaxilla (ANL/PrNL), premaxilla to cranial base (PrEL/SoEL), 
upper incisors to cranial base (BuEL/SoEL), premaxilla to cranial vault (PrEL/PoEL), premaxilla 
to cranial vault (BuEL/PoEL), upper incisor inclination (MuPrL/PrIuL), lower incisor inclination 
and (MlIiL/IdIiL), are due to the unique spatial activity of the Wnt1-Cre driver.  Since the skull 
base connects the posterior and mid-facial regions, the shortened skull base is a well-known cause 
of mid-facial defects [24, 26]. Therefore, our data suggest that the differential Cre recombination 
efficiency mediated by the Wnt1-Cre and P0-Cre lineage cells within the anterior part of the skull 
base leads to the differential impacts on the pre-mature fusion of ISS and the length of the skull 
base, which secondarily leads to the shortened and downward-angled facial defects observed in 
the Evc2 Wnt1 mutants.  
Similar to the appendicular bones, the skull base develops through endochondral 
ossification, wherein the cartilage primordium forms first, followed by mineral deposition. The 
proliferation and maturation of chondrocytes at the synchondrosis in the skull base is quite 
important for skull base elongation [26]. In this study, we found loss of function of Evc2 results in 
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premature closure of the ISS, which connects the presphenoid bone and the basisphenoid bone, 
before P8 in Evc2 global mutant and in Evc2 Wnt1 mutant. We previously reported that loss of 
function of Evc2 results in severe chondrodysplastic dwarfism; however, we never observed 
premature closure of appendicular growth plates through adult stages [16]. Those data suggest that 
a function of Evc2 to maintain cartilage is different between appendicular growth plates and 
synchondroses. A potential mechanism leading to the premature fusion of ISS is a subject under 
active investigation.  
In this study, we used both P0-Cre and Wnt1-Cre to specifically delete Evc2 in the neural 
crest derived cells. Despite largely overlapping targeted regions within the facial regions of P0-
Cre and Wnt1-Cre [21, 22] (our own comparisons, data not shown), small differences have been 
noticed between those Cre lines by multiple studies [27-30]. Particularly, our recent studies 
demonstrated that both P0-Cre and Wnt1-Cre differentially target neural crest cells emerging at 
the anterior, middle and posterior portions of the head during embryogenesis [30]. Previously, we 
reported a neural crest-specific disruption of TGF-beta activating kinase 1 (Tak1) using Wnt1-Cre 
and P0-Cre, respectively [31, 32]. While Tak1 P0 mutants do not show overt craniofacial 
phenotypes at the birth [31], Tak1 Wnt1 mutants develop cleft palate secondarily to the 
micrognathia [32]. This is another example that Wnt1-Cre and P0-Cre result in distinctive 
phenotypes. In the current study, we identified that P0-Cre and Wnt1-Cre differentially target the 
anterior regions of the skull base, and we took advantage of those differences to identify the 
pathophysiological mechanism leading to the mid-facial defects in Evc2 mutant mice. However, 
there is a formal possibility that the differential Cre activity within the unknown types of cells or 
tissues contributing to the differential mid-facial defects in Evc2 P0 mutants and Wnt1 mutants. 
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We will further investigate an involvement of the premature fusion of the ISS to the mid-facial 
defects in our mutant mouse models. 
Wnt1-Cre is known to target the brain [21], while P0-Cre is not expressed in the central 
nervous system. However, it is unlikely that the differential mid-facial defects observed in the 
Evc2 Wnt1 mutants and Evc2 P0 mutants are secondary effects of the differential Cre targeting 
within the brain. Firstly, the mid-facial region is not in direct contact with the brain and thus brain 
development should not have an impact on the development of the mid-facial region. Secondly, 
despite the fact that Evc2 is a positive regulator of Hedgehog signaling, there are no brain 
developmental defects observed in patients or mice. Recent studies also suggest that the transgenic 
construct in Wnt1-Cre mouse line transiently elevates WNT signaling during craniofacial 
development [33]. It is unlikely that this is the reason leading to differential mid-facial defects 
observed in the Evc2 Wnt1 mutants and Evc2 P0 mutants. Our analysis demonstrated that no overt 
head shape differences between Evc2 fl/+ and Evc2 fl/+; Wnt1-Cre, suggesting the transiently 
elevated WNT signaling due to Wnt1-Cre did not leads to craniofacial abnormalities.  
By specifically deleting Evc2 in neural crest-derived tissues, we were able to generate a 
mouse model of human EvC that recapitulates the mid-facial defects associated with EvC 
syndrome. Multiple analyses at different developmental stages confirm the critical role of the skull 
base during face elongation and development within the first month and demonstrate that the mid-
facial defects in EvC syndrome are largely due to the premature fusion of the ISS in the skull base. 
Examination and targeting the shortened skull is therefore a suggested therapeutic option for the 








Figure 4.7: Skull bone superimposition. 
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A. Superimposition of each skull bones within the Evc2 P0 group. Comparisons of two controls 
(Evc2 P0 C vs. C) and three additional pairs of control and mutant (Evc2 P0 C vs. m) are shown. 
B. Superimposition of each skull bones within the Evc2 Wnt1 group. Comparisons of two 
controls (Evc2 Wnt1 C vs. C) and three additional pairs of control and mutant (Evc2 Wnt1 C vs. 




Figure 4.8: Evc2 expression in synchondrosis in the skull base. 
Beta-galactosidase activity from the lacZ knock-in allele of Evc2 locus was used as a surrogate 
of the expression of Evc2. The skull bases from Evc2lacZ/+ at P10 were stained with X-gal 
followed by eosin counter staining. Robust staining (blue) was detected in the ISS and the SOS. 
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Chapter 5: Role of Evc2/Limbin on molar morphology and oral function 
 
5.1 Introduction 
As the gateway to the body, structural variation within the craniofacial region has 
significant health and nutritional impacts that extend beyond its anatomic boundaries. Dysfunction 
within this region requires functional adaptation or compensation for the sustenance of life and, 
long-term, confers increased risk of metabolic disorders that pose a significant clinical burden [1–
3]. The impact of nutritional imbalance coupled with the high incidence of human craniofacial 
anomalies make the process of mastication a critical component when studying the functional and 
physiological outcomes of musculoskeletal disorders within this region [4]. Mastication is the 
rhythmic reduction of ingested food into smaller particles that maximize enzymatic interaction, 
digestive efficiency, and nutrient acquisition [5]. This process is uniquely a mammalian behavior 
that requires precise motor input and coordination of craniofacial musculature and components of 
the cranial system, specifically the jaws and teeth [6,7]. 
Ingested items represent conglomerates of non-uniform particle size and masticatory 
effectiveness is defined as the completeness with which a defined amount of material is reduced 
to a certain mean particle size [8]. Efficiency can be determined via a standardized wet sieve 
protocol that has been applied to studies involving numerous mammalian species [9,10]. Factors 
affecting efficiency include tooth anatomy and number as well as chewing force, duration, 
direction, and intensity. Studies have shown that greater efficiency, which is represented by a lower 
mean fecal particle size (FPS), is correlated with tooth number and surface area complexity (e.g., 
age-related attrition), factors also related to chewing frequency, bite force, food choice (e.g., soft 
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food preference), and longevity [1,7,8,11–13]. While many of these variables can be measured and 
controlled for in a laboratory setting, FPS represents a conveniently non-invasive alternative for 
assessing efficiency. Unlike digesta (i.e., food within the stomach that has not entered the 
intestines), fecal material has passed through the entire digestive tract and has been exposed to 
additional changes. However, these changes are small and only significant when feeding on soft 
material (e.g., kelp) [14,15]. 
Ellis-van Creveld syndrome (EVC; MIM ID #225500) is a rare congenital disorder that 
significantly affects the craniofacial region. Although characterized by more conspicuous signs 
such as disproportionate dwarfism and postaxial polydactyly (e.g., 6-7 fingers per appendage), 
patients present with a dental phenotype that includes hypoplastic enamel, congenitally missing 
teeth (i.e., hypodontia), abnormally shaped teeth (e.g., taurodontic or bulbous teeth), and premature 
eruption and exfoliation [16–19]. Patients also develop a progressively abnormal craniofacial 
morphology which includes mandibular prognathism, maxillary deficiency, skeletal open bite, and 
prominent frontal bossing that gives patients a concave-shaped lateral profile. These individuals 
thus require extensive prosthodontic rehabilitation (e.g., dentures and implants) and orthodontic 
management beginning from a young age [20,21]. Despite craniofacial signs suggesting 
significantly impaired chewing efficiency, detailed descriptions of molar morphology and oral 
function in patients with EVC are limited.  
Mouse models for EVC were developed by targeting orthologs of the two causative genes 
(i.e., Evc or Evc2/Limbin) and have been critical for providing insight into disease pathogenesis 
[22–26]. Evc2/Limbin is highly expressed in the skull base and facial skeleton (i.e., 
viscerocranium), both of which are derived from neural crest cells (NCCs) [26–28]. NCCs 
represent a special population of migratory cells that contribute to mineralized structures within 
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the craniofacial region and maintain their identity despite divergence from the ectoderm in early 
gastrulation [29]. NCC-specific conditional knockout animal models of Evc2/Limbin (referred to 
as Evc2/Limbin-cKO) have revealed that expression within these cells is important for determining 
craniofacial morphology, results in abnormal incisors reminiscent of those in EVC patients, and 
circumvents perinatal lethality issues seen in conventional or global knockout animal models 
[25,30,31]. Furthermore, muscles of mastication are not derived from NCCs [32] suggesting that 
functional deficits are fundamental outcomes of dysmorphology in NCC-derived structures. 
Whether NCC-driven anatomic variation results in oral functional alteration and deficiency has 
yet to be investigated and is necessary to both broaden our understanding of functional disease 
outcomes and further the utility of Evc2/Limbin-cKO as a model of human disease.  
In this study, we report molar dysmorphology and chewing functional deficits in NCC-
specific Evc2/Limbin-cKO mice. Despite no change in the total number of molars, those present 
in Evc2/Limbin-cKO mice were taurodontic and had less complex coronal anatomy. These dental 
morphologic findings complement our previous craniofacial observations and, collectively, 
recapitulate signs seen in patients with EVC. Chewing functional metrics such as chewing rate and 
bite force were also reduced in Evc2/Limbin-cKO mice. However, despite evidence to suggest 
reduced chewing efficiency, average FPS was not different between Evc2/Limbin-cKO mice and 
their control counterparts. These findings suggest the presence of an adaptive mechanism that 





5.2 Materials and Methods 
5.2.1 Animal Model 
All animals and experiments were performed in accordance with the policies and federal 
laws for the judicious use of vertebrate animals, as approved by the Institutional Animal Care and 
Use Committee at the University of Michigan. Evc2/Limbin floxed mice were generated by our 
group and reported previously [33]. Neural crest cell (NCC)-specific conditional knockout mice 
for Evc2/Limbin (referred to as Evc2/Limbin-cKO) were created by crossing Evc2/Limbin floxed 
mice with Wnt1-Cre mice[34]. “Control” animals did not have Evc2/Limbin homozygous deletions 
(i.e., Evc2fx/+;Wnt1(-), Evc2fx/fx;Wnt1(-), or Evc2fx/+;Wnt1(+)) and were compared against their 
Evc2/Limbin-cKO (i.e., Evc2fx/fx;Wnt1(+)) littermates. Analyses were performed at postnatal days 
P28, P42, P66, and P120. 
 
5.2.2 μCT Imaging 
Micro-CT scanning of fixed heads was performed at the University of Michigan using a 
Micro-CT core (μCT40 Scanco Medical, Bassersdorf, Switzerland). Scan settings were the 
following: voxel size 18μm, 55kVp, 109μA, 0.5mm AL filter, and integration time 500ms. 
 
5.2.3 Image Segmentation and Analysis 
Structures of interest were segmented and converted to 3D mesh models from μCT data 
using ITK-SNAP (itksnap.org, open source software developed by grants and contracts from the 
United States National Institutes of Health). Individual molar linear measurements (i.e., 
mesiodistal length, buccolingual width, incisocervical length) and volumes were divided into 
coronal and radicular segments using the cementoenamel junction (CEJ) as a boundary. 
Incisocervical length, mesiodistal length, buccolingual width, and linear distances between 
landmarks (Tables 5.1 and 5.2) were computed using the “CMF Reg tool” and “Q3DC tool” 
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developed in 3D Slicer (slicer.org, open source software). Molar occlusal surface areas, defined as 
all suprabulge polygons visible from the coronal view, were acquired and computed in MeshLab 
(Institute of Information Science and Technologies, Pisa, Italy). Normalized occlusal surface area 
(Sn) was calculated as follows: 
 
Sn = Sm / Ss 
 
Sm represents the surface area (mm
2) of all suprabulge surface polygons of a single molar. 
Ss represents the surface area of a sphere with the same volume as a molar’s crown. Using the 
known volume (Vm; mm
3) of the molar crown: 
 
Ss = 4π * (3/4π)
2/3 * (Vm)














5.2.4 Fluoroscopic Recording 
Sterilized 0.25mm diameter spherical tantalum markers (Bal-Tec, Los Angeles, CA, USA) 
were implanted in the cranium and jaw while animals were under general anesthesia (1-5% 
isoflurane with balanced O2). Briefly, indentations were made using saline irrigation and a dental 
handpiece (1500rpm maximum) equipped with a 0.25mm round carbide bur. Markers were then 
Description
Bu Point on the premaxilla between the jaw bone and the lingual surface of the upper 
incisors
Mu Point on the intersection between the maxillary bone and mesial surface of the upper 
first molar
U1 Point on the mesial occlusal fossa of the upper first molar 
U3 Point on the distal occlusal fossa of the upper third molar
U4 Point on the intersection between the maxillary bone and distal surface of the upper 
third molar
Mf Center of the mandibular fossa in the temporal bone
Ml Point on the intersection between the mandibular alveolar bone and the mesial surface 
of the first molar
Bl Point on the intersection between the lingual surface of the lower incisors and the most 
anterior part of the lingual alveolar bone
Gn Point on the most inferior contour of the angular process of the mandible
Go The most posterior point on the angular process of the mandible
L1 Point on the mesial occlusal fossa of the lower first molar
L3 Point on the distal occlusal fossa of the lower third molar
L4 Point on the intersection between the mandibular bone and the distal surface of the 
lower third molar






Mf-Mu Length of longest maxillary tooth lever
Mf-U4 Length of shortest maxillary tooth lever
Mf-Bu Effective upper jaw length
U1-U3 Length of upper occlusal table
Ml-Bl Mandibular lingual alveolar bone length
Go-Ml Length of longest mandibular tooth lever
Go-L4 Length of shortest mandibular tooth lever
Go-Bl Effective mandibular length







seated within the indentations and immobilized using Vetbond (3M, St. Paul, MN, USA). Animals 
were given an intramuscular injection of carprofen (5mg/kg) following surgery and monitored 
daily through 7 days post-surgery for signs of discomfort (e.g., scruffy appearance and/or lethargy) 
and suture hygiene. 
High-speed biplanar fluoroscopy was recorded at 250 frames/s using two synchronized 
high-speed video cameras (Oqus 310; Qualisys, Göteborg, Sweden) mounted on the output ports 
of two fluoroscopes [OEC-9000 (General Electrics, Boston, MA, USA) refurbished by 
Radiological Imaging Services (Hamburg, PA, USA)]. On average, radiation exposures were set 
at 80 kVp and 4.5 mA to provide sufficient contrast between markers and bones. Recordings were 
initiated upon the start of chewing and lasted ~10s. Replicate recordings were captured a minimum 
of 1 hour after initial radiation exposure, after which animals were euthanized via CO2 overdose 
followed by bilateral pneumothorax.  
 
5.2.5 High Speed Video Acquisition 
High-speed video from the sagittal view was recorded at 300 frames/s using a digital 
camera (EX-F1; Casio, Tokyo, Japan). Recordings were initiated upon the start of chewing and 
lasted 10s. Replicate recordings were captured a minimum of 1 hour after initial data acquisition. 
 
5.2.6 Chewing Frequency Determination 
Chewing frequency was determined from either high-speed fluoroscopic (see Section 
5.2.4) or digital recordings (see Section 5.2.5) using either XMALab (open source software 
developed by grants and contracts from the United States National Science Foundation) or Kinovea 
(kinovea.org, open source software), respectively. Chew cycles were defined by the period of time 
or number of frames between maximum jaw openings; single chews were omitted from analysis. 
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Bursts of >3 rhythmic chews and no less than 15 chews/trial were used to calculate mean chewing 
frequency per animal. 
 
5.2.7 Bite Force Measurement 
Bite force was recorded using a piezo electric force transducer (model 9203, Amherst, NY, 
USA) mounted between two parallel steel plates separated by 0.5-1 mm and attached to an 
amplifier (model 5995, Kistler). The transducer was calibrated prior to each trial session to ensure 
linear readings across its entire range. Briefly, hand-restrained mice were brought into proximity 
of the parallel bite plates which they readily and rhythmically bit. Maximal bite force readings 
were extracted using LabChart 8 (ADInstruments, Colorado Springs, CO, USA). Animals were 
given 15 minutes of rest between replicate trials. 
 
5.2.8 Food Processing Rate 
Food processing rate was defined as the amount of time needed to ingest food (i.e., single 
autoclaved, unsalted sunflower seed) of a given mass. Time recording was initiated upon the start 
of visible food processing and continued until either: (1) the seed was completely consumed or (2) 
a total time of 5 minutes, after which remaining material was collected and weighed. Trials per 
tested individual were scored as either “finished” (i.e., seed completely consumed within the 5 
minutes) or “not finished” (i.e., seed partially consumed with material remaining after 5 minutes). 
 
5.2.9 Fecal Particle Sorting 
Fecal samples collected over the course of 1 week from mice fed a standard chow diet 
(LabDiet, St. Louis, MO, USA), were stored at 4°C until sorting and analysis. Briefly, samples 
were desiccated at 103°C overnight then rehydrated in water under gentle agitation (55rpm on 
Lab-Line orbital shaker; Barnstead, Dubuque, IA, USA) for 3 hours. Rehydrated samples were 
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then rinsed with water at a rate of 2L/min through wire mesh sieves [pore sequence (μm): 2000-
850-425-250-125-63-32] placed on a sieve shaker (Performer III SS-3, Gilson, Lewis Center, OH, 
USA) for 15 minutes. Sorted samples were again dried at 103°C overnight before final weighing. 
Mean fecal particle size was calculated according to the Fritz et al. 2012: 
 






Sieves are ordered from size S(1) (minimum) up to S(n) (maximum pore size). Because the 
proportion of dried material p(i) retained on a sieve includes particles smaller than S(n+1) but 
larger than S(n), particles on S(n) were converted to an average between S(n) and S(n+1).  
 
5.2.10 Statistical Analysis 
Comparisons between 2 groups were analyzed by Student t-test (*p < 0.05; **p < 0.01; 
***p < 0.001, **** p< 0.0001). All tests were performed using the statistical software Microsoft 




5.3.1 Molar numbers are unchanged in Evc2/Limbin-cKO mice 
Neural crest-specific disruption of Evc2/Limbin does not affect the number of molars (i.e., 
3) per quadrant in Evc2/Limbin-cKO mice (Figure 5.1 A). Both maxillary and mandibular molars 
were aligned along a clear occlusal plane and were positioned appropriately (i.e., mandibular 
molars approximately ½ tooth length ahead of maxillary molars) so that none were expected to be 
unopposed during mastication. However, 2 of 5 Evc2/Limbin-cKO mice analyzed at postnatal day 
P28 exhibited unilateral fusion of the first 2 molars in either the mandibular or maxillary arch 
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(Figure 5.1 B). These observations suggest that any changes in chewing performance in 
Evc2/Limbin-cKO mice would reflect finer scale differences in tooth morphology as opposed to 




Figure 5.1: Comparison of gross dental and craniofacial morphology. 
(A) Lingual view of mandibular left molars in Control and Evc2/Limbin-cKO mutants. (B) 
Single tomographic images illustrating abnormal fusion of the two anteriormost molars in cKO 
mice. (C) Diagram indicating linear measurements with significant differences. Significantly 
increased measurements are shown in green and significantly decreased measurements are 
shown in red. (D) Graphs indicating measurements (also shown on C) with significant 
differences between Control and Evc2/Limbin-cKO mutants (N=4-5 at P28, * p < 0.05). Values 
are averages ± SD. 
 
5.3.2 Evc2/Limbin-cKO mice have abnormal molar proportions 
We previously reported incisor dysmorphology in this and another neural crest cell-specific 
Evc2/Limbin-cKO mouse model [31]. Molars of Evc2/Limbin-cKO mice at P28 were dysmorphic 
and appeared “bulbous” or taurodontic due to abnormal radicular and coronal proportions (Figure 
5.2 A, B). Crown to root length ratio (measured in the incisocervical dimension) was significantly 
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larger in Evc2/Limbin-cKO mice suggesting the presence of either longer crowns or shorter roots 
(Figure 5.2 C). Reduced coronal buccolingual to mesiodistal length ratios further indicated that 
molar occlusal surfaces were rounder than those of their control counterparts (Figure 5.2 D). 
Though these trends (i.e., longer and rounder crowns) held true for most Evc2/Limbin-cKO mouse 
molars, changes in morphology were most pronounced in the second most anterior teeth in both 
arches. Coincidentally, these teeth were also the largest teeth in their respective arches (Figure 
Supplemental 5.5 A-H) suggesting that the observed morphologic changes could have a 
proportionate effect on chewing performance.  
The ordinal difference between the largest molar tooth in Evc2/Limbin-cKO mice and their 
control counterparts (i.e., second most anterior vs. anteriormost, respectively) led us to reconsider 
the identity of each molar in Evc2/Limbin-cKO mice despite no change in total tooth number. 
Though discernible in both the maxillary and mandibular arches, morphologic differences were 
most apparent for the anteriormost mandibular molar (Figure 5.2 A, B). Although mice do not 
have premolars, this tooth (referred to as M0) had proportions dissimilar to any Evc2/Limbin-cKO 
or control molars and consistently had a spherical crown and single, conical root – features similar 
to mandibular premolars described in other mammals [35]. Additional embryonic data suggesting 
that these anteriormost “molars” represent either vestigial premolars or abnormal tooth buds 
resulting from conditional Evc2/Limbin deletion led us to reorder Evc2/Limbin-cKO molars as M0-
M1-M2 and speculate that M3 failed to develop (Figure 5.7). Because the identities of anteriormost 
(i.e., M0) and posteriormost (i.e., M3) molars remain suppositions based on current evidence, we 






Figure 5.2: Differential molar morphology. 
(A) Occlusal view of mandibular left molars (maxillary and mandibular) illustrating changes in 
crown morphology in Control and Evc2/Limbin-cKO mutants. (B) Incisal view of the same 
molars illustrating changes in root morphology. Graphs of molar measurements are as follows: 
(C) crown:root length ratio measured in the incisocervical direction, (D) 
buccolingual:mesiodistal length ratio, (E) crown:root volume, and (F) normalized coronal 
surface area. (N=4-5 for Control and Evc2/Limbin-cKO mutants at P28, respectively; * p < 0.05, 
** p<0.01, *** p<0.001, **** p<0.0001). Values are averages ± SD. 
 
 
5.3.3 Molar volumes are reduced in Evc2/Limbin-cKO mice 
We next assessed molar coronal and radicular volumes to further confirm the basis of 
“bulbous” or taurodontic tooth appearance. Although all volumes (i.e., whole tooth, coronal, and 
radicular) were significantly smaller in Evc2/Limbin-cKO mice at P28, their significantly larger 
crown to root volume ratios indicated the presence of disproportionally large crowns (Figures 5.2 
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E and 5.5 E-G). However, this volume ratio disparity may have be compounded by root 
dysmorphology as those of Evc2/Limbin-cKO mice were consistently fused into a single, conical-
like structure vs. the 3 or 2 roots seen in control maxillary and mandibular molars, respectively. 
The volumetric and linear measurement results suggest that Evc2/Limbin expression in neural crest 
cells plays a role in both overall tooth morphology (e.g., crown shape and root number) and root 
elongation. In the context of chewing performance, altered crown morphology could reduce the 
surface available for mechanical food reduction thereby decreasing efficiency. 
 
5.3.4 Molar coronal surfaces are less complex in Evc2/Limbin-cKO mice 
We next investigated coronal surface morphology as this represents the critical interfacial 
site between teeth and ingested material. Cusp identification in Evc2/Limbin-cKO molars was 
unreliable due to abnormal and irregular crown morphology. Linear measurements indicated that, 
compared to controls, Evc2/Limbin-cKO mice had reduced arch lengths and less coronal surface 
area (Figures 5.1 C-D and 5.5 H). These results were unsurprising considering the reduced molar 
size in Evc2/Limbin-cKO mice at P28 (Figure 5.5 A-G). However, normalization of surface area 
against crown volume revealed that Evc2/Limbin-cKO mice had less complex crown morphology, 
evidence suggestive of decreased mechanical reductive capacity (Figure 5.2 F). This trend of 
decreased surface complexity was consistent amongst Evc2/Limbin-cKO molars except for the 
second most anterior mandibular molar (M1) which had a characteristic deep pit in its distal half 
(Figure 5.2 A). Because molar morphologic analyses were performed at P28 (i.e., shortly after 
weaning and the transition to hard food), we assumed that any alterations in chewing functions 
(i.e., chewing rate or bite force) or efficiency represent fundamental outcomes of conditional 
Evc2/Limbin deletion-induced tooth morphologic changes. 
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5.3.5 Chewing rate is decreased in Evc2/Limbin-cKO mice 
Mammalian mastication represents the cumulative output of coordinated interactions 
between the nervous system and craniofacial structures (i.e., jaws, teeth, and muscles of 
mastication). Because the muscles of mastication are non-neural crest derived, we first turned to 
chewing rate as a means of assessing whether NCC-driven anatomic (i.e., dental and craniofacial) 
variation results in oral functional changes. Sexually mature Evc2/Limbin-cKO mice at P120 
chewed significantly slower and with more inter-cycle timing variation than their control 
counterparts (Figures 5.3 A and B). Fewer chews per unit time translates to lessened cumulative 
stress applied to ingested particles and thereby suggests decreased food reductive efficiency. 
However, chewing involves multiple inputs and additional functional evidence was needed to 
support this conclusion.   
 
 
Figure 5.3: Oral performance measures in mature mice. 
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(A) Chewing rate of mice at P120. (B) Chewing rate variation (reported as SEM) in mice at 
P120. (C) Bite force of mice at P66. (N=4-6 for Control and Evc2/Limbin-cKO, respectively; * p 
< 0.05). Values are averages ± SD unless otherwise noted. 
 
 
5.3.6 Bite force is reduced in Evc2/Limbin-cKO mice 
Since mechanical reduction is affected by both the duration and magnitude (e.g., number 
of chews and force, respectively) of applied forces, we next assessed maximal bite force in 
Evc2/Limbin-cKO mice. Bite force of Evc2/Limbin-cKO mice was significantly reduced at P67 
compared to their control counterparts (Figure 5.3 C). Though bite force scales with body size (i.e., 
greater bite force with increased body mass) and though Evc2/Limbin-cKO mice are ~30% smaller 
by body weight (Figure 5.6), the marked reduction in bite force defies established models and was 
interpreted as a representation of functional deficiency. This evidence also compliments chewing 
rate data and, since both involve the same craniofacial structures, further suggests that chewing 
efficiency should be compromised by Evc2/Limbin-deletion induced molar variation.  
 
5.3.7 Fecal particle size is not affected in Evc2/Limbin-cKO mice 
Molar morphologic and chewing functional data collectively suggest that chewing 
efficiency should be decreased in Evc2/Limbin-cKO mice. However, neither average fecal particle 
size nor particle distribution at P120 significantly differed between Evc2/Limbin-cKO and control 
mice (Figures 5.4 A and B). The similar values between experimental groups yet significant 
differences compared to undigested food (Figure 5.4 A and B) was surprising and insinuates the 






Figure 5.4: Measures of chewing performance in mature mice. 
(A) Average fecal particle size of mice at P120 compared to standard chow diet. (B) Distribution 
of recovered particles within sorted feces and standard chow diet. (N=4 for Control and 6 for 
Evc2/Limbin-cKO, respectively; * p < 0.05). Values are averages ± SD (C) Number of 
individuals either finishing or not finishing a standardized food item (i.e., sunflower seed) during 
a 5 min food processing trial. (N=4 for Control and 2 for Evc2/Limbin-cKO, respectively) 
 
 
5.3.8 Feeding bouts are increased in Evc2/Limbin-cKO mice 
We finally sought to identify how Evc2/Limbin-cKO mice could be compensating for 
anatomic deficiencies. We turned to behavioral modification over gastrointestinal changes (e.g., 
gut motility) since Evc2/Limbin expression was conditionally disrupted in neural crest cells which 
widely contribute to structures of the head and neck region. Compared to controls, which were 
able to finish the given task within 5 min (4 out of 4), processing time for a given amount of food 
was significantly increased for the cKO (i.e., none of them finished processing the food within 5 
min (2 out of 2)) (Figure 5.4 C). Therefore, Evc2/Limbin-cKO mice may compensate for less 





This work used X-ray computed microtomography and digital segmentation to describe the 
3-dimensional morphology of molars in Evc2/Limbin-cKO mice. While high resolution imaging 
is neither necessary nor feasible for most clinical cases, its application provided critical insight 
into the diminutive dental anatomic variations resulting from Evc2/Limbin deletion in neural crest 
cells. Tooth formation requires spatiotemporally coordinated interaction between cells of different 
origin (i.e., ectodermal-derived dental epithelium and neural crest-derived dental mesenchyme) 
[36,37]. Following prenatal crown completion, postnatal root formation begins with the apical 
migration and fusion of the inner and outer enamel epithelium into a structure called Hertwig’s 
epithelial root sheath (HERS). The epithelial derived HERS subsequently affects root morphology 
as well as root dentin formation through its interaction with mesenchymal cells of the dental papilla 
[38,39]. Observed differences in both crown and root morphology in Evc2/Limbin-cKO mice 
suggests that Evc2/Limbin expression in neural crest cells is: (1) necessary for both prenatal crown 
development and postnatal root elongation and (2) secondarily affects non-NCC derived structures 
such as enamel. Though this study did not attempt to expound upon the mechanisms of NCC and 
non-NCC interaction in the teeth and craniofacial musculature, the importance of Evc2/Limbin 
during perinatal developmental stages critically aligns with our previous observations where 
Evc2/Limbin-cKO mouse incisor and midfacial dysmorphology is present shortly after birth and 
becomes progressively worse with postnatal age [31]. 
Evc2/Limbin-cKO mice provide a clinically relevant model of a human disease and tool 
for studying the oral functional outcomes following fundamental changes in craniofacial 
morphology. The recapitulation of molar phenotypes (e.g., taurodontic molars with conical roots) 
between human patients and Evc2/Limbin-cKO mice provides insights into the mechanism of 
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disease pathogenesis [18,19,40]. For example, previous studies have shown that Hedgehog (Hh) 
signaling is attenuated in a different (note: non-NCC specific) conditional knockout model for 
Evc2/Limbin [41]. Though it would be overly simplistic to attribute all phenotypic outcomes to 
disruptions in Hh signaling, Hh expression in the dental epithelium (note: non-NCC derived) is 
regulated by the NCC-derived dental mesenchyme and, critically, determines crown size and root 
length [42–44]. Disruptions in Hh signaling also affect tooth number and patterning thereby 
providing insight into the identity of anteriormost molars observed in this study [44,45]. 
Regardless, the presence of fundamental differences in dental morphology and prolonged survival 
of Evc2/Limbin-cKO mice to advanced ages — postnatal lethality is common is both human 
patients with EVC and conventional or global knockout mouse models — establishes them as a 
convenient tool for assessing oral function.  
Interactions between mesodermal and neural crest-derived structures extend beyond 
perinatal dental and craniofacial development. In terms of functional interaction, none are more 
important for sustained survival than the rhythmic coordination between muscles, teeth, and jaws 
during feeding. Variables such as tooth number (e.g., total number and opposing or functional 
units) and quality (e.g., coronal anatomy and integrity) as well as chewing force, duration, and 
magnitude all affect the crushing efficiency that occurs during mastication [7,8]. Though most 
patients with EVC are described as having congenitally missing and/or abnormal teeth, changes in 
chewing efficiency would likely reflect anterior vs. posterior presentation patterns, specifically the 
bias towards misshapen posterior teeth (i.e., molars and premolars)[18,19]. Rhythmic food 
reduction occurs along the occlusal surfaces of posterior teeth which are misshapen, but do not 
differ in terms of total number or functional (i.e., opposing upper and lower tooth) units, in both 
human EVC patients and Evc2/Limbin-cKO mice. This molar phenotypic consistency and the 
147 
 
demonstration of reduced occlusal surface area in Evc2/Limbin-cKO mice further supports their 
use as a clinically relevant disease model and tool for elucidating the effects of finer scale tooth 
changes on chewing performance.  
As previously mentioned, chewing effectiveness is a byproduct of dental anatomic form 
and function during chewing behaviors. Despite collective anatomic (i.e., molar shape and surface 
area) and functional evidence (i.e., decreased bite force and chewing rate) suggesting that chewing 
effectiveness would be reduced in Evc2/Limbin-cKO mice, the insignificant difference in average 
fecal particle size indicated that Evc2/Limbin-cKO mice compensated for their anatomical 
shortcomings. Chewing behavior adaptation in this study manifested as prolonged food processing 
time (i.e., greater total number of chews) since Evc2/Limbin-cKO mice were, unlike their control 
counterparts, unable to consume a single sunflower seed during a 5-minute feeding trial. Extended 
feeding bouts increase the period of tooth/food interaction and, in the absence of pre-processing 
(e.g., licking to soften food or using cutlery to mechanically reduce items), represent 
straightforward compensatory behavioral modifications employed by humans and non-human 
primates alike[11,46,47]. However, because feeding bout length represents a single component of 
chewing behavior, it would be interesting to assess per chew particle reduction since: (1) each 
cycle exponentially reduces food particle size within the ingested bolus and (2) significantly more 
or lesser quality chews (e.g., chewing stroke alterations) may indicate other sources of variation 
(e.g., pain)[8]. Regardless, both the limitations of modification and whether readouts assessed in 
this study represent function and/or efficiency in innate or non-adapted states requires further 
investigation. For example, enamel hypoplasia or structural abnormalities in the 
temporomandibular joint may cause physical discomfort thereby altering bite force and chewing 
rate. Variation in the muscle size and fiber orientations within the tongue and masticatory muscles 
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may also interfere with bolus manipulation and the generation of sufficient masticatory forces 
necessary for reduction.  
In conclusion, we report changes in molar root and crown shape as well as decreased 
coronal complexity in a neural crest cell specific knockout mouse model for Evc2/Limbin. These 
mice attain similar measures of chewing efficiency and compensate for both structural and 
functional deficiencies (e.g., molar dysmorphology, decreased bite force, and reduced chewing 
rate) by increasing the length of feeding bouts. This detailed description of dental anatomic 
variation and oral function in an animal model of EVC provides a foundation for future studies 




Figure 5.5: Non-normalized measurements 
Graphs of measurements are as follows: (A) incisocervical crown length. (B) incisocervical root 
length, (C) maximal buccolingual molar width, (D) maximal mesiodistal molar length, (E) crown 
volume (mm3), (F) root volume (mm3), (G) whole molar volume (mm3), (H) coronal surface area 
(mm2). (N=4-5 for Control and Evc2/Limbin-cKO mutants at P28, respectively; * p < 0.05, ** 






Figure 5.6: Comparison of Control and Evc2/Limbin-cKO body mass 
Body mass of mice used for analysis. (N=4-5 for Control and Evc2/Limbin-cKO mutants at P28, 




Figure 5.7: Ectopic anteriormost molar in Evc2/Limbin-cKO mice. 
Immunofluorescence indicating the locations of SHH (red) and LEF1 (green) in the mandible at 
e16.5. SHH labels the enamel knot. LEF1 labels WNT signaling responsive cells within the 
dental mesenchyme. Anteriormost molar in Evc2/Limbin-cKO panel (bottom) is smaller and 
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Chapter 6: Summary and Future Work 
 
6.1 Regulation of Complex Tissue Regeneration 
Based on our previous studies (Chapter 1.2) indicating the occurrence of cellular 
reprogramming following craniofacial muscle injury, we utilized an unbiased high throughput 
approach to identify how this process is temporally regulated at the transcriptional level (Chapter 
2). This work not only investigated a novel regeneration model and modality that circumvents an 
inherent issue (i.e., lack sufficient numbers of replacement cells) of many tissue engineering 
approaches, but challenged the prevailing notion that regeneration recapitulates embryonic 
development (Chapter 3).  
Analysis of differentially expressed genes (DEG) at two time points early in the muscle 
regeneration process (i.e., 9 and 18 hours post injury (hpi)) allowed us to identify over 6000 
candidates that could play a role in craniofacial muscle regeneration. Due to the large number of 
candidates, we next applied two types of gene annotation analyses (i.e., gene ontology (GO) terms 
and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways) and discovered consistency 
between the results. Convinced of the validity of annotation-based conclusions, we then sought to 
identify pathways that supported published observations and mechanisms within our muscle 
regeneration model. Downregulated terms and pathways included those involved in muscle 
differentiation, development, and function – reassuring findings considering the loss of myocyte 
identity and muscle-to-mesenchymal transition observed in the injured muscle stump. Upregulated 
terms and pathways included catabolic and lysosomal processes – also reassuring findings 
considering the necessity of autophagy in our muscle regeneration model.  
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Though subsequent clustering of DEG based on temporal expression patterns further 
validated our regeneration model, the identification of transiently upregulated genes critically 
revealed that epigenetic modification may underlie myocyte reprogramming. Genes within the 
“transient upregulation” group (i.e., differential expression only at 9hpi) included known 
epigenetic regulators including ezh2, prmt5, and prmt7. In vivo knockdown experiments revealed 
that these genes were necessary for both cellular reprogramming – assessed as the percentage of 
proliferating myoblast-like cells present – and anatomic regeneration. This differed from a “late 
upregulation” (i.e., differential expression at 18hpi) gene such as the extracellular matrix 
component fn1a which was necessary for anatomic regeneration but not cellular reprogramming.  
Also among the “transient upregulation” cluster of DEG were those encoding twist 
transcription factors, elements known to affect craniofacial muscle development and epithelial to 
mesenchymal transitions during tumorigenesis. Of the 4 zebrafish twist paralogs (i.e., twist1a, 
twist1b, twist2, and twist3), we discovered that only twist3 was necessary for adult muscle 
regeneration and did so by affecting early steps (i.e., cellular reprogramming as assessed by 
myoblast proliferation) during this process. This role differed from twist1a, twist1b, and twist2 
which were previously shown to affect craniofacial morphology and which we demonstrated were 
necessary for embryonic extraocular muscle development. Results from this work not only support 
the potential of our identified DEG as targets for regenerative therapies but suggest that, despite 
subfunctionalization amongst paralogs, twist transcription factors have an evolutionarily 
conserved role during myogenesis.  
 
6.2 Craniofacial Dysmorphology and Oral Functional Outcomes 
Using our unique mouse model of a rare human genetic disorder (Chapter 1.1), we 
investigated the etiology of craniofacial dysmorphology (Chapter 4) using a combined 
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cephalometric and tomographic imaging approach. The midfacial phenotypic similarities between 
our model and human patients with Ellis-van Creveld syndrome (EVC) further supported its 
clinical relevance and led us to consider additional utility as a tool for assessing oral function in 
fundamentally altered craniofacial states. Novel analyses of molar morphology and chewing 
effectiveness (Chapter 5) revealed how animals compensate for suboptimal craniofacial 
morphology and may provide insight into rehabilitation strategies and functional assessments in 
similarly affected human patients. 
Conventional or global knockout (KO) mouse models of EVC recapitulate many human 
disease signs, including high levels of postnatal lethality. We circumvented this issue and studied 
the role of a causative gene (i.e., Evc2) in the craniofacial region by conditionally knocking it out 
(cKO) in neural crest-derived cells. Cephalometric analyses at multiple time points (i.e., postnatal 
days P8 and P28) and using two different neural crest-specific Cre-recombinase divers (i.e., Wnt1-
Cre and P0-Cre) demonstrated differences in skull shape and facial profile which, generally, 
became worse with advancing age. Significantly different angular and linear measurements 
between the skulls of cKO and control mice predominantly involved structures within the 
neurocranium and viscerocranium, regions with significant contributions from neural crest cells. 
These changes in craniofacial measurements within both cKO mouse lines were also comparable 
KO mice suggesting that Evc2 expression in neural crest cells is important during craniofacial 
development.  
Despite superficial similarities between Wnt1-Cre and P0-Cre mice at P8, more 
widespread angle-based craniofacial dysmorphology in Wnt1-Cre mice at P28 led us to investigate 
the etiology of these differences. Shape-based analyses indicated significant shortening of the 
neural crest-derived anterior skull base coincident with premature fusion of the intrasphenoidal 
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synchondrosis. These results were also supported by higher recombination efficiency within the 
anterior skull base of Wnt1-Cre mice. Considering how the skull base serves as the connector 
between posterior and anterior skull elements and its effects upon facial profile, we concluded that 
skull base deficiencies secondarily lead to midfacial dysmorphology in both Evc2-cKO mice and 
human EVC patients.   
After establishing Evc2-cKO mice as a clinically relevant model with fundamental changes 
in craniofacial morphology, we then used it as a tool to investigate the relationship between form 
and function within this region. Mastication represented a convenient readout of complex 
interactions between neural crest and non-neural crest derived structures (e.g., jaws, teeth, and 
masticatory muscles) and parameters such as bite force and chewing rate were significantly 
decreased in Evc2-cKO mice. Shape-based analysis of molar teeth also confirmed taurodontism 
and indicated reduced coronal surface area complexity. However, the insignificant differences in 
chewing efficiency suggest that animals compensated for anatomic shortcomings via behavioral 
modification (i.e., increase feeding bout length). Results from this work thereby provide insight 
into the adaptive strategies used to sustain function and, ultimately, survival following changes in 
craniofacial morphology.  
 
 
6.3 Future Work 
The work in this dissertation sought to address the need to achieve both anatomic 
regeneration and restoration of function following congenital or traumatic changes in craniofacial 
morphology. Investigation into the temporal regulation of adult tissue regeneration and gene 
subfunctionalization has led to the identification of multiple pathways that represent potentially 
druggable targets for future regenerative therapies. Assessment and characterization of the 
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functional outcomes in states of congenital craniofacial dysmorphology provide insight into form-
function relationships and represent potential metrics by which successful rehabilitation may be 
measured. However, future studies must further elucidate the mechanisms underlying tissue 
regeneration as well as assess adaptation by evaluating function at various developmental or post-
acute injury time points.  
Knockdown experiments provided the phenotypic validation necessary to conclude that 
specific DEG were important during the muscle regeneration process. However, time availability 
and the lack of reactive anti-zebrafish antibodies precluded comprehensive testing of all 6000 
DEG. Epigenetic modifications present attractive targets for future studies and/or therapeutics 
considering: (1) overrepresentation of the GO term “regulation of gene expression, epigenetic” 
within our gene set and (2) the demonstrated importance of genes (i.e., ezh2 and suz12a) involved 
in histone methylation and epigenetic silencing. The reversible nature of epigenetic modifications 
also fits the narrative of cellular reprogramming while conserved chromatin structure across 
species allows antibody-based validation of translational knockdown. Specific targets of interest 
include the likes of prmt1 and hdac1 – genes involved in histone methylation and deacetylation 
machinery, respectively – as well as zebrafish paralogs of pluripotency markers (e.g., myca and 
mycb).  
Our functional investigation using Evc2-cKO mice suggested that changes in molar 
morphology and surface characteristics were associated with decreases in chewing metrics (i.e., 
bite force and chewing rate). However, these changes were seemingly compensated for by 
increased food processing time (i.e., chewing bout) resulting in non-significant changes in average 
fecal particle size or distribution. Whether changes in tooth morphology or chewing performance 
(i.e., bite force and chewing rate) inherently affect chewing effectiveness requires further 
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investigation. Issues that must be addressed are: (1) the temporal development of compensatory 
mechanisms and (2) effect of acute (e.g., mechanically induced) changes to coronal anatomy. 
Chewing metrics and performance were assessed in sexually mature mice that had been feeding 
on standard chow for >2months. Because mice could have potentially developed compensatory 
behaviors over this time, it is necessary to repeat testing at an early point (e.g., P28 or shortly after 
weaning) to determine the presence or absence of innate functional deficiency. A complimentary 
approach to additional testing of cKO mice would be to induce acute changes (e.g., tooth extraction 
or occlusal reduction) and assess functional outcomes immediately following modification. These 
experiments are important next steps to uncovering the relationship between oral form and function 
using our mouse model. 
In conclusion, the work in this dissertation uses two vastly different models united under 
the overall goal of uncovering the basis of craniofacial muscle regeneration leading to restoration 
of chewing function. Application of and insight gained by using these tools establishes an 
influential platform for discovery that extends beyond the gateway of the mouth. 
 
